BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: van der Post RS, Vogelaar IP, Carneiro F, Guilford P, Huntsman D, Hoogerbrugge N, Caldas C, Schreiber KE, Hardwick RH, Ausems MG, Bardram L, Benusiglio PR, Bisseling TM, Blair V, Bleiker E, Boussioutas A, Cats A, Coit D, DeGregorio L, Figueiredo J, Ford JM, Heijkoop E, Hermens R, Humar B, Kaurah P, Keller G, Lai J, Ligtenberg MJ, O'Donovan M, Oliveira C, Pinheiro H, Ragunath K, Rasenberg E, Richardson S, Roviello F, Schackert H, Seruca R, Taylor A, Ter Huurne A, Tischkowitz M, Joe ST, van Dijck B, van Grieken NC, van Hillegersberg R, van Sandick JW, Vehof R, van Krieken JH, Fitzgerald RC. Hereditary diffuse gastric cancer: updated clinical guidelines with an emphasis on germline CDH1 mutation carriers. J Med Genet. 2015;52:361-374. [PMID: 25979631 DOI: 10.1136/jmedgenet-2015-103094] [Cited by in Crossref: 365] [Cited by in F6Publishing: 387] [Article Influence: 45.6] [Reference Citation Analysis]
Number Citing Articles
1 Kővari B, Wen KW, Lauwers GY. Epithelial Polyps and Neoplasms of the Stomach. Gastrointestinal and Liver Pathology 2024. [DOI: 10.1016/b978-0-323-52794-1.00004-3] [Reference Citation Analysis]
2 Muranaka F, Kise E, Tokumaru S, Kitazawa M, Miyagawa Y, Suga T, Uehara T, Iwaya M, Kobayashi S, Sato M, Gomi D, Yamada H, Sugimura H, Kosho T, Soejima Y, Koizumi T. Hereditary diffuse gastric cancer in a Japanese family with CDH1 mutation three case reports. Discov Oncol 2023;14:14. [PMID: 36719602 DOI: 10.1007/s12672-023-00623-4] [Reference Citation Analysis]
3 Knipper K, Fuchs HF, Alakus H, Bruns CJ, Schmidt T. [Hereditary diffuse gastric cancer]. Chirurgie (Heidelb) 2023. [PMID: 36700973 DOI: 10.1007/s00104-023-01806-z] [Reference Citation Analysis]
4 Garcia-Pelaez J, Barbosa-Matos R, Lobo S, Dias A, Garrido L, Castedo S, Sousa S, Pinheiro H, Sousa L, Monteiro R, Maqueda JJ, Fernandes S, Carneiro F, Pinto N, Lemos C, Pinto C, Teixeira MR, Aretz S, Bajalica-Lagercrantz S, Balmaña J, Blatnik A, Benusiglio PR, Blanluet M, Bours V, Brems H, Brunet J, Calistri D, Capellá G, Carrera S, Colas C, Dahan K, de Putter R, Desseignés C, Domínguez-Garrido E, Egas C, Evans DG, Feret D, Fewings E, Fitzgerald RC, Coulet F, Garcia-Barcina M, Genuardi M, Golmard L, Hackmann K, Hanson H, Holinski-Feder E, Hüneburg R, Krajc M, Lagerstedt-Robinson K, Lázaro C, Ligtenberg MJL, Martínez-Bouzas C, Merino S, Michils G, Novaković S, Patiño-García A, Ranzani GN, Schröck E, Silva I, Silveira C, Soto JL, Spier I, Steinke-Lange V, Tedaldi G, Tejada MI, Woodward ER, Tischkowitz M, Hoogerbrugge N, Oliveira C. Genotype-first approach to identify associations between CDH1 germline variants and cancer phenotypes: a multicentre study by the European Reference Network on Genetic Tumour Risk Syndromes. Lancet Oncol 2023;24:91-106. [PMID: 36436516 DOI: 10.1016/S1470-2045(22)00643-X] [Reference Citation Analysis]
5 Röcken C. Predictive biomarkers in gastric cancer. J Cancer Res Clin Oncol 2023;149:467-81. [PMID: 36260159 DOI: 10.1007/s00432-022-04408-0] [Reference Citation Analysis]
6 Lee CYC, Olivier A, Honing J, Lydon AM, Richardson S, O'Donovan M, Tischkowitz M, Fitzgerald RC, di Pietro M. Endoscopic surveillance with systematic random biopsy for the early diagnosis of hereditary diffuse gastric cancer: a prospective 16-year longitudinal cohort study. Lancet Oncol 2023;24:107-16. [PMID: 36509094 DOI: 10.1016/S1470-2045(22)00700-8] [Reference Citation Analysis]
7 Subaşıoğlu A, Güç ZG, Gür EÖ, Tekindal MA, Atahan MK. Genetic, Surgical and Oncological Approach to Breast Cancer, with BRCA1, BRCA2, CDH1, PALB2, PTEN and TP53 Variants. Eur J Breast Health 2023;19:55-69. [PMID: 36605468 DOI: 10.4274/ejbh.galenos.2022.2022-7-2] [Reference Citation Analysis]
8 Kole C, Charalampakis N, Sakellariou S, Papaxoinis G, Apostolou KG, Machairas N, Papanikolaou IS, Schizas D. Hereditary Diffuse Gastric Cancer: A 2022 Update. J Pers Med 2022;12. [PMID: 36556253 DOI: 10.3390/jpm12122032] [Reference Citation Analysis]
9 Stillman MD, Kusche N, Toledano S, Hilfrank KJ, Yoon C, Gabre JT, Rustgi SD, Hur C, Kastrinos F, Ryeom SW, Yoon SS. Short and long-term outcomes of prophylactic total gastrectomy in 54 consecutive individuals with germline pathogenic mutations in the CDH1 gene. J Surg Oncol 2022;126:1413-22. [PMID: 36063148 DOI: 10.1002/jso.27084] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Ben Aissa-Haj J, Pinheiro H, Cornelis F, Sebai M, Meseure D, Briaux A, Berteaux P, Lefol C, Des Guetz G, Trassard M, Stevens D, Vialard F, Bieche I, Noguès C, Tang R, Oliveira C, Stoppat-Lyonnet D, Lidereau R, Rouleau E. The Identification of Large Rearrangements Involving Intron 2 of the CDH1 Gene in BRCA1/2 Negative and Breast Cancer Susceptibility. Genes (Basel) 2022;13. [PMID: 36553480 DOI: 10.3390/genes13122213] [Reference Citation Analysis]
11 Lin B, Liu Y, Su L, Liu H, Feng H, Yu M, Liu H. A Novel CDH1 Variant Identified in a Chinese Family with Blepharocheilodontic Syndrome. Diagnostics (Basel) 2022;12. [PMID: 36552944 DOI: 10.3390/diagnostics12122936] [Reference Citation Analysis]
12 Stanich PP, Elgindi D, Stoffel E, Koeppe E, Bansal A, Stetson R, Collins DL, Clark DF, Karloski E, Dudley B, Brand RE, Hall MJ, Chertock Y, Sullivan BA, Muller C, Hinton A, Katona BW, Kupfer SS. Colorectal Neoplasia in CDH1 Pathogenic Variant Carriers: A Multicenter Analysis. Am J Gastroenterol 2022;117:1877-9. [PMID: 36087100 DOI: 10.14309/ajg.0000000000001996] [Reference Citation Analysis]
13 van Bekkum S, Menke‐pluijmers MBE, Westenend PJ. Gastric metastasis of breast cancer: A frequent mimicker of primary gastric cancer in breast cancer patients. JGH Open 2022;6:804-808. [DOI: 10.1002/jgh3.12824] [Reference Citation Analysis]
14 Tian HK, Zhang Z, Ning ZK, Liu J, Liu ZT, Huang HY, Zong Z, Li H. Clinicopathological characteristics and prognosis of gastric signet ring cell carcinoma. World J Clin Cases 2022; 10(29): 10451-10466 [DOI: 10.12998/wjcc.v10.i29.10451] [Reference Citation Analysis]
15 Long JM, Ebrahimzadeh J, Stanich PP, Katona BW. Endoscopic Surveillance in Patients with the Highest Risk of Gastric Cancer: Challenges and Solutions. Cancer Manag Res 2022;14:2953-69. [PMID: 36238953 DOI: 10.2147/CMAR.S277898] [Reference Citation Analysis]
16 Shah IH, Salo-Mullen EE, Amoroso KA, Kelsen D, Stadler ZK, Hamilton JG. Attitudes toward preimplantation genetic testing and quality of life among individuals with hereditary diffuse gastric cancer syndrome. Hered Cancer Clin Pract 2022;20:31. [PMID: 36056367 DOI: 10.1186/s13053-022-00239-9] [Reference Citation Analysis]
17 Sweidan K, Elfadel H, Sabbah DA, Bardaweel SK, Hajjo R, Anjum S, Sinoj J, Nair VA, Abu‐gharbieh E, El‐huneidi W. Novel Derivatives of 4,6‐Dihydroxy‐2‐Quinolone‐3‐Carboxamides as Potential PI3Kα Inhibitors. ChemistrySelect 2022;7. [DOI: 10.1002/slct.202202263] [Reference Citation Analysis]
18 . Causes of Genetic Conditions and Laboratory and Testing Approaches. Medical Genetics and Genomics 2022. [DOI: 10.1002/9781119847212.ch4] [Reference Citation Analysis]
19 Drubay V, Nuytens F, Renaud F, Adenis A, Eveno C, Piessen G. Poorly cohesive cells gastric carcinoma including signet-ring cell cancer: Updated review of definition, classification and therapeutic management. World J Gastrointest Oncol 2022; 14(8): 1406-1428 [DOI: 10.4251/wjgo.v14.i8.1406] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
20 Dardenne A, Sirmai L, Metras J, Enea D, Svrcek M, Benusiglio PR. Prédispositions génétiques au cancer gastrique et leur association au type histologique. Bulletin du Cancer 2022. [DOI: 10.1016/j.bulcan.2022.06.010] [Reference Citation Analysis]
21 Schölzchen J, Treese C, Thuss-patience P, Mrózek A, Rau B, Seeliger H, Hartmann D, Estevéz-schwarz L, Siegmund B, Horn D, Nassir M, Daum S. Frequency of Positive Familial Criteria in Patients with Adenocarcinoma of the Esophageal-Gastric Junction and Stomach: First Prospective Data in a Caucasian Cohort. Cancers 2022;14:3590. [DOI: 10.3390/cancers14153590] [Reference Citation Analysis]
22 Uspenskiy YP, Baryshnikova NV, Krasnov AA, Petlenko SV, Apryatina VA. Topical issues of prevention of stomach cancer: A review. Consilium Medicum 2022;24:358-364. [DOI: 10.26442/20751753.2022.5.201922] [Reference Citation Analysis]
23 Cosma LS, Schlosser S, Tews HC, Müller M, Kandulski A. Hereditary Diffuse Gastric Cancer: Molecular Genetics, Biological Mechanisms and Current Therapeutic Approaches. Int J Mol Sci 2022;23:7821. [PMID: 35887173 DOI: 10.3390/ijms23147821] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
24 Zavros Y, Merchant JL. The immune microenvironment in gastric adenocarcinoma. Nat Rev Gastroenterol Hepatol 2022;19:451-67. [PMID: 35288702 DOI: 10.1038/s41575-022-00591-0] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
25 Carneiro VCG, Gifoni ACLVC, Rossi BM, da Cunha Andrade CEM, de Lima FT, de Campos Reis Galvão H, da Rocha JCC, da Silva Barreto LS, Ashton‐prolla P, Guindalini RSC, de Farias TP, Andrade WP, de Sousa Fernandes PH, Ribeiro R, Lopes A, Tsunoda AT, Azevedo BRB, Marins CAM, de Albuquerque Oliveira Uchôa DN, Dos Santos EAS, Coimbra FJF, Filho FAD, de Oliveira Lopes FC, Fernandes FG, Ritt GF, Laporte GA, Guimaraes GC, Feitosa e Castro Neto H, dos Santos JC, de Carvalho Vilela JB, Junior JGM, da Cunha JR, Milhomem LM, da Silva LM, de Freitas Maciel L, Ramalho NM, Nunes RL, de Araújo RG, de Assunção Ehrhardt R, Bocanegra RED, Junior TCS, de Oliveira VR, Surimã WS, de Melo Melquiades M, de Castro Ribeiro HS, Oliveira AF. Cancer risk‐reducing surgery: Brazilian Society of Surgical Oncology Guideline Part 2 (Gastrointestinal and thyroid). Journal of Surgical Oncology 2022;126:20-27. [DOI: 10.1002/jso.26813] [Reference Citation Analysis]
26 Cerrato-Izaguirre D, Chirino YI, García-Cuellar CM, Santibáñez-Andrade M, Prada D, Hernández-Guerrero A, Larraga OA, Camacho J, Sánchez-Pérez Y. Mutational landscape of gastric adenocarcinoma in Latin America: A genetic approach for precision medicine. Genes Dis 2022;9:928-40. [PMID: 35685475 DOI: 10.1016/j.gendis.2021.04.002] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
27 Kovalenko NV, Zhavoronkova VV, Postolov MP, Suvorov VA. Hereditary diffuse gastric cancer syndrome: medical genetic consulting, treatment strategy for family members, prophylactic total gastrectomy, and endoscopic surveillance in CDH1- and CTNNA1-mutation carriers. Sib onkol ž 2022;21:126-134. [DOI: 10.21294/1814-4861-2022-21-3-126-134] [Reference Citation Analysis]
28 Alhalabi MM, Alsayd SA, Albattah ME. Advanced diffuse gastric adenocarcinoma in young Syrian woman. A case report. Annals of Medicine and Surgery 2022;78:103728. [DOI: 10.1016/j.amsu.2022.103728] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
29 Carneiro F. Familial and hereditary gastric cancer, an overview. Best Pract Res Clin Gastroenterol 2022;58-59:101800. [PMID: 35988963 DOI: 10.1016/j.bpg.2022.101800] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
30 Ruf B, Roggia C, Schroeder C, Mattern S, Fend F, Klag T, Götz M. Chromoendoscopy in Combination with Random Biopsies for Patients with Pathogenic CDH1 Mutations Undergoing Endoscopic Surveillance. J Gastrointest Canc. [DOI: 10.1007/s12029-022-00831-1] [Reference Citation Analysis]
31 Zarrilli G, Angerilli V, Cappellesso R, Galuppini F, Pennelli G, Farinati F, Nicolè L, Savarino E, Realdon S, Griguolo G, Bottosso M, Dieci MV, Guarneri V, Tos APD, Mele ML, Fassan M. Gastric metastases of breast cancer: histopathological and molecular characterization of a single Institution case series. Pathology - Research and Practice 2022. [DOI: 10.1016/j.prp.2022.153872] [Reference Citation Analysis]
32 Treese C, Siegmund B, Daum S. Hereditary Diffuse Gastric Cancer—Update Based on the Current Consort Recommendations. Current Oncology 2022;29:2454-60. [DOI: 10.3390/curroncol29040199] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
33 Mouabbi JA, Hassan A, Lim B, Hortobagyi GN, Tripathy D, Layman RM. Invasive lobular carcinoma: an understudied emergent subtype of breast cancer. Breast Cancer Res Treat. [DOI: 10.1007/s10549-022-06572-w] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 7.0] [Reference Citation Analysis]
34 Soda T, Gen Y, Terasaki K, Iwai N, Kitaichi T, Dohi O, Taketani H, Seko Y, Umemura A, Nishikawa T, Yamaguchi K, Moriguchi M, Konishi H, Naito Y, Itoh Y, Yasui K. Loss of KAP3 decreases intercellular adhesion and impairs intracellular transport of laminin in signet ring cell carcinoma of the stomach. Sci Rep 2022;12:5050. [PMID: 35322078 DOI: 10.1038/s41598-022-08904-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
35 Corso G. Pleiotropic cancer manifestations of germline CDH1 mutations: Risks and management. Journal of Surgical Oncology. [DOI: 10.1002/jso.26847] [Reference Citation Analysis]
36 Uetake Y, Kojima S, Ogawa F, Kojima N, Mori M, Yajima K, Ho Kim D. A Case of Clinically Suspected Hereditary Diffuse Gastric Cancer with a History of Lobular Breast Cancer and Multiple Diffuse Gastric Cancer. Jpn J Gastroenterol Surg, Nihon Shokaki Geka Gakkai zasshi 2022;55:73-81. [DOI: 10.5833/jjgs.2020.0180] [Reference Citation Analysis]
37 Lerner BA, Xicola RM, Rodriguez NJ, Karam R, Llor X. Simplified and more sensitive criteria for identifying individuals with pathogenic CDH1 variants. J Med Genet 2023;60:36-40. [PMID: 35078942 DOI: 10.1136/jmedgenet-2021-108169] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
38 Sinnamon AJ, Pimiento JM, Roses RE. The Role of Surgery in Management of Gastric Cancer. Cancer Metastasis Through the Lymphovascular System 2022. [DOI: 10.1007/978-3-030-93084-4_39] [Reference Citation Analysis]
39 Corso G, Magnoni F, Trovato C, Girardi A, Seruca R, Figueiredo J, Roviello F. Hereditary Gastric Cancer: A New Syndrome. Gastric Cancer: the 25-year R-Evolution 2022. [DOI: 10.1007/978-3-030-73158-8_5] [Reference Citation Analysis]
40 Huber-keener KJ. Cancer Genetics and Breast Cancer. Best Practice & Research Clinical Obstetrics & Gynaecology 2022. [DOI: 10.1016/j.bpobgyn.2022.01.007] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
41 Adib E, El Zarif T, Nassar AH, Akl EW, Abou Alaiwi S, Mouhieddine TH, Esplin ED, Hatchell K, Nielsen SM, Rana HQ, Choueiri TK, Kwiatkowski DJ, Sonpavde G. CDH1 germline variants are enriched in patients with colorectal cancer, gastric cancer, and breast cancer. Br J Cancer 2021. [PMID: 34949788 DOI: 10.1038/s41416-021-01673-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
42 Shen L, Zhang S, Wang K, Wang X. Familial Breast Cancer: Disease Related Gene Mutations and Screening Strategies for Chinese Population. Front Oncol 2021;11:740227. [PMID: 34926254 DOI: 10.3389/fonc.2021.740227] [Reference Citation Analysis]
43 Besova NS, Kalinin AE, Nered SN, Triakin AA, Gamaiunov SV, Kozlov NA, Stilidi IS, Karachun AM, Kononets PV, Malikhova OA, Riabov AB, Khomiakov VM, Fedenko AA, Bolotina LV, Falaleeva NA, Nevol'skikh AA, Ivanov SA, Khailova ZV, Gevorkian TG, Butenko AV, Gil'mutdinova IR, Eremushkin MA, Ivanova GE, Kondrat'eva KO, Konchugova TV, Krutov AA, Obukhova OA, Semiglazova TI, Filonenko EV, Khulamkhanova MM, Romanov AI. Gastric cancer: Russian clinical guidelines. J Mod Onco 2021;23:541-571. [DOI: 10.26442/18151434.2021.4.201239] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
44 Kohoutova D, Banks M, Bures J. Advances in the Aetiology & Endoscopic Detection and Management of Early Gastric Cancer. Cancers (Basel) 2021;13:6242. [PMID: 34944861 DOI: 10.3390/cancers13246242] [Reference Citation Analysis]
45 Garcia-Pelaez J, Barbosa-Matos R, São José C, Sousa S, Gullo I, Hoogerbrugge N, Carneiro F, Oliveira C. Gastric cancer genetic predisposition and clinical presentations: Established heritable causes and potential candidate genes. Eur J Med Genet 2022;65:104401. [PMID: 34871783 DOI: 10.1016/j.ejmg.2021.104401] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
46 Hallowell N, Badger S, Lawton J. Eating to live or living to eat: The meaning of hunger following gastric surgery. SSM - Qualitative Research in Health 2021;1:100005. [DOI: 10.1016/j.ssmqr.2021.100005] [Reference Citation Analysis]
47 Li M, Rao X, Cui Y, Zhang L, Li X, Wang B, Zheng Y, Teng L, Zhou T, Zhuo W. The keratin 17/YAP/IL6 axis contributes to E-cadherin loss and aggressiveness of diffuse gastric cancer. Oncogene 2021. [PMID: 34845376 DOI: 10.1038/s41388-021-02119-3] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
48 Hacker U, Hoffmeister A, Lordick F. [Gastric Cancer: diagnosis and current treatment strategies]. Dtsch Med Wochenschr 2021;146:1533-7. [PMID: 34826839 DOI: 10.1055/a-1169-0440] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
49 Yao C, Li Y, Luo L, Xiong Q, Zhong X, Xie F, Feng P. Identification of miRNAs and genes for predicting Barrett's esophagus progressing to esophageal adenocarcinoma using miRNA-mRNA integrated analysis. PLoS One 2021;16:e0260353. [PMID: 34818353 DOI: 10.1371/journal.pone.0260353] [Reference Citation Analysis]
50 Gamble LA, Davis JL. Surveillance and Surgical Considerations in Hereditary Diffuse Gastric Cancer. Gastrointest Endosc Clin N Am 2022;32:163-75. [PMID: 34798984 DOI: 10.1016/j.giec.2021.08.009] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
51 Wang JE, Kim SE, Lee BE, Park S, Hwang JH, Huang RJ. The risk of diffuse-type gastric cancer following diagnosis with gastric precancerous lesions: a systematic review and meta-analysis. Cancer Causes Control 2021. [PMID: 34797436 DOI: 10.1007/s10552-021-01522-1] [Reference Citation Analysis]
52 Liu Q, Jiang J, Zhang X, Zhang M, Fu Y. Comprehensive Analysis of IGFBPs as Biomarkers in Gastric Cancer. Front Oncol 2021;11:723131. [PMID: 34745945 DOI: 10.3389/fonc.2021.723131] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
53 McVeigh UM, Tepper JW, McVeigh TP. A Review of Breast Cancer Risk Factors in Adolescents and Young Adults. Cancers (Basel) 2021;13:5552. [PMID: 34771713 DOI: 10.3390/cancers13215552] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
54 Pouw RE, Barret M, Biermann K, Bisschops R, Czakó L, Gecse KB, de Hertogh G, Hucl T, Iacucci M, Jansen M, Rutter M, Savarino E, Spaander MCW, Schmidt PT, Vieth M, Dinis-Ribeiro M, van Hooft JE. Endoscopic tissue sampling - Part 1: Upper gastrointestinal and hepatopancreatobiliary tracts. European Society of Gastrointestinal Endoscopy (ESGE) Guideline. Endoscopy 2021;53:1174-88. [PMID: 34535035 DOI: 10.1055/a-1611-5091] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 10.0] [Reference Citation Analysis]
55 Zimmer K, Kocher F, Puccini A, Seeber A. Targeting BRCA and DNA Damage Repair Genes in GI Cancers: Pathophysiology and Clinical Perspectives. Front Oncol 2021;11:662055. [PMID: 34707985 DOI: 10.3389/fonc.2021.662055] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
56 Taja-Chayeb L, Vidal-Millán S, Trejo-Becerril C, Pérez-Cárdenas E, Chávez-Blanco A, Domínguez-Gómez G, González-Fierro A, Romo-Pérez A, Dueñas-González A. Hereditary Diffuse Gastric Cancer (HDGC). An overview. Clin Res Hepatol Gastroenterol 2021;:101820. [PMID: 34656755 DOI: 10.1016/j.clinre.2021.101820] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
57 Zhang YJ, Yang Y, Wei Q, Xu T, Zhang XT, Gao J, Tan SY, Liu BR, Zhang JD, Chen XB, Wang ZJ, Qiu M, Wang X, Shen L, Wang XC. A multicenter study assessing the prevalence of germline genetic alterations in Chinese gastric-cancer patients. Gastroenterol Rep (Oxf) 2021;9:339-49. [PMID: 34567566 DOI: 10.1093/gastro/goab020] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
58 Pan Z, Fu Z, Luo C, Bao Y, Wang M, Cao W, Xu X. CDH1 germline mutations in a Chinese cohort with hereditary diffuse gastric cancer. J Cancer Res Clin Oncol 2021. [PMID: 34537906 DOI: 10.1007/s00432-021-03775-4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
59 Barbosa-Matos R, Leal Silva R, Garrido L, Aguiar AC, Garcia-Pelaez J, André A, Seixas S, Sousa SP, Ferro L, Vilarinho L, Gullo I, Devezas V, Oliveira R, Fernandes S, Costa SC, Magalhães A, Baptista M, Carneiro F, Pinheiro H, Castedo S, Oliveira C. The CDH1 c.1901C>T Variant: A Founder Variant in the Portuguese Population with Severe Impact in mRNA Splicing. Cancers (Basel) 2021;13:4464. [PMID: 34503274 DOI: 10.3390/cancers13174464] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
60 Gullo I, Grillo F, Mastracci L, Vanoli A, Carneiro F, Saragoni L, Limarzi F, Ferro J, Parente P, Fassan M. Precancerous lesions of the stomach, gastric cancer and hereditary gastric cancer syndromes. Pathologica 2020;112:166-85. [PMID: 33179620 DOI: 10.32074/1591-951X-166] [Cited by in Crossref: 15] [Cited by in F6Publishing: 18] [Article Influence: 7.5] [Reference Citation Analysis]
61 Besova NS. Nivolumab as a representative of immune checkpoint inhibitors in late-line treatment for disseminated gastric cancer. Medicinskij sovet 2021. [DOI: 10.21518/2079-701x-2021-9-96-107] [Reference Citation Analysis]
62 Hinoi T. Cancer Genomic Profiling in Colorectal Cancer: Current Challenges in Subtyping Colorectal Cancers Based on Somatic and Germline Variants. J Anus Rectum Colon 2021;5:213-28. [PMID: 34395933 DOI: 10.23922/jarc.2021-009] [Reference Citation Analysis]
63 Maccaroni E, Giampieri R, Lenci E, Scortichini L, Bianchi F, Belvederesi L, Brugiati C, Pagliaretta S, Ambrosini E, Berardi R. BRCA mutations and gastrointestinal cancers: When to expect the unexpected? World J Clin Oncol 2021; 12(7): 565-580 [PMID: 34367929 DOI: 10.5306/wjco.v12.i7.565] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
64 Katoh H, Ishikawa S. Lifestyles, genetics, and future perspectives on gastric cancer in east Asian populations. J Hum Genet 2021;66:887-99. [PMID: 34267306 DOI: 10.1038/s10038-021-00960-8] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
65 Carreño M, Pena-Couso L, Mercadillo F, Perea J, Urioste M. Investigation on the Role of PALB2 Gene in CDH1-Negative Patients With Hereditary Diffuse Gastric Cancer. Clin Transl Gastroenterol 2020;11:e00280. [PMID: 33512806 DOI: 10.14309/ctg.0000000000000280] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
66 Hoskins C, Tutty E, Purvis R, Shanahan M, Boussioutas A, Forrest L. Young people's experiences of a CDH1 pathogenic variant: Decision-making about gastric cancer risk management. J Genet Couns 2021. [PMID: 34265132 DOI: 10.1002/jgc4.1478] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
67 Furth EE. Grossing of Gastrointestinal Specimens: Best Practices and Current Controversies. Surg Pathol Clin 2020;13:359-70. [PMID: 32773188 DOI: 10.1016/j.path.2020.04.001] [Reference Citation Analysis]
68 Dixon K, Senz J, Kaurah P, Huntsman DG, Schrader KA. Rare APC promoter 1B variants in gastric cancer kindreds unselected for fundic gland polyposis. Gut 2021;70:1415-6. [PMID: 32895333 DOI: 10.1136/gutjnl-2020-321990] [Reference Citation Analysis]
69 Sánchez Fuentes PA, Vidaña Márquez E, Velasco Albendea FJ. Hereditary diffuse CDH1 positive gastric cancer. Prophylactic gastrectomy? Medicina Clínica (English Edition) 2021;157:46-48. [DOI: 10.1016/j.medcle.2020.04.055] [Reference Citation Analysis]
70 Solsky I, In H. Surgical Treatment for Gastric Cancer. Gastrointest Endosc Clin N Am 2021;31:581-605. [PMID: 34053640 DOI: 10.1016/j.giec.2021.04.001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
71 Wang FH, Zhang XT, Li YF, Tang L, Qu XJ, Ying JE, Zhang J, Sun LY, Lin RB, Qiu H, Wang C, Qiu MZ, Cai MY, Wu Q, Liu H, Guan WL, Zhou AP, Zhang YJ, Liu TS, Bi F, Yuan XL, Rao SX, Xin Y, Sheng WQ, Xu HM, Li GX, Ji JF, Zhou ZW, Liang H, Zhang YQ, Jin J, Shen L, Li J, Xu RH. The Chinese Society of Clinical Oncology (CSCO): Clinical guidelines for the diagnosis and treatment of gastric cancer, 2021. Cancer Commun (Lond) 2021;41:747-95. [PMID: 34197702 DOI: 10.1002/cac2.12193] [Cited by in Crossref: 111] [Cited by in F6Publishing: 115] [Article Influence: 55.5] [Reference Citation Analysis]
72 Ithurralde-Argerich J, Rosner L, Rizzolo M, Faerberg A, Puma R, Ferro D, Duque C, Kujaruk M, Cuenca-Abente F. Laparoscopic Prophylactic Total Gastrectomy for Hereditary Diffuse Gastric Cancer in CDH1 Mutation Carriers. J Laparoendosc Adv Surg Tech A 2021;31:729-37. [PMID: 34097461 DOI: 10.1089/lap.2021.0239] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
73 Rustgi SD, Ching CK, Kastrinos F. Inherited Predisposition to Gastric Cancer. Gastrointest Endosc Clin N Am 2021;31:467-87. [PMID: 34053634 DOI: 10.1016/j.giec.2021.03.010] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
74 Benesch MGK, Bursey SR, O'Connell AC, Ryan MG, Howard CL, Stockley CC, Mathieson A. CDH1 Gene Mutation Hereditary Diffuse Gastric Cancer Outcomes: Analysis of a Large Cohort, Systematic Review of Endoscopic Surveillance, and Secondary Cancer Risk Postulation. Cancers (Basel) 2021;13:2622. [PMID: 34073553 DOI: 10.3390/cancers13112622] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
75 Okamoto T, Suzuki H, Fukuda K. Simultaneous gastric cancer and breast cancer metastases to the stomach with lymph node collision tumor: a case report. BMC Gastroenterol 2021;21:240. [PMID: 34034653 DOI: 10.1186/s12876-021-01823-4] [Reference Citation Analysis]
76 Tedaldi G, Molinari C, São José C, Barbosa-Matos R, André A, Danesi R, Arcangeli V, Ravegnani M, Saragoni L, Morgagni P, Rebuzzi F, Canale M, Pignatta S, Ferracci E, Martinelli G, Ranzani GN, Oliveira C, Calistri D, Ulivi P. Genetic and Epigenetic Alterations of CDH1 Regulatory Regions in Hereditary and Sporadic Gastric Cancer. Pharmaceuticals (Basel) 2021;14:457. [PMID: 34066170 DOI: 10.3390/ph14050457] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
77 Nikaido M, Kakiuchi N, Miyamoto S, Hirano T, Takeuchi Y, Funakoshi T, Yokoyama A, Ogasawara T, Yamamoto Y, Yamada A, Setoyama T, Shimizu T, Kato Y, Uose S, Sakurai T, Minamiguchi S, Obama K, Sakai Y, Muto M, Chiba T, Ogawa S, Seno H. Indolent feature of Helicobacter pylori-uninfected intramucosal signet ring cell carcinomas with CDH1 mutations. Gastric Cancer 2021;24:1102-14. [PMID: 33961152 DOI: 10.1007/s10120-021-01191-8] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
78 Dang DNT, Nguyen HTT, Ngo HD, Tran BM, Vu AD, Dang HQ, Ta VT. A novel stop codon mutation in exon 5 (c.639G>A) of the cadherin-1 gene in a Vietnamese man with hereditary diffuse gastric cancer: a case report. J Med Case Rep 2021;15:263. [PMID: 33941229 DOI: 10.1186/s13256-021-02837-y] [Reference Citation Analysis]
79 Bar-Mashiah A, Soper ER, Cullina S, Belbin GM, Kenny EE, Lucas AL, Abul-Husn NS. CDH1 pathogenic variants and cancer risk in an unselected patient population. Fam Cancer 2021. [PMID: 33886068 DOI: 10.1007/s10689-021-00257-x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
80 Chen D, Li C, Zhao Y, Zhou J, Wang Q, Xie Y. Bioinformatics analysis for the identification of differentially expressed genes and related signaling pathways in H. pylori-CagA transfected gastric cancer cells. PeerJ 2021;9:e11203. [PMID: 33954041 DOI: 10.7717/peerj.11203] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
81 Amada E, Kawakubo H, Matsuda S, Mayanagi S, Nakamura R, Irino T, Wada N, Mikami S, Kitagawa Y. A case of synchronous intramucosal gastric carcinoma with multiple lymph node metastases. Surg Case Rep 2021;7:80. [PMID: 33797633 DOI: 10.1186/s40792-021-01149-z] [Reference Citation Analysis]
82 Gamble LA, Heller T, Davis JL. Hereditary Diffuse Gastric Cancer Syndrome and the Role of CDH1: A Review. JAMA Surg 2021;156:387-92. [PMID: 33404644 DOI: 10.1001/jamasurg.2020.6155] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
83 Lerner BA, Llor X. Genetic Gastric Cancer Risk Syndromes. Curr Treat Options Gastroenterol 2020;18:604-15. [PMID: 33776403 DOI: 10.1007/s11938-020-00312-z] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
84 Fornaro L, Spallanzani A, de Vita F, D'Ugo D, Falcone A, Lorenzon L, Tirino G, Cascinu S; GAIN (GAstric Cancer Italian Network). Beyond the Guidelines: The Grey Zones of the Management of Gastric Cancer. Consensus Statements from the Gastric Cancer Italian Network (GAIN). Cancers (Basel) 2021;13:1304. [PMID: 33804024 DOI: 10.3390/cancers13061304] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
85 Corso G, Corso F, Bellerba F, Carneiro P, Seixas S, Cioffi A, La Vecchia C, Magnoni F, Bonanni B, Veronesi P, Gandini S, Figueiredo J. Geographical Distribution of E-cadherin Germline Mutations in the Context of Diffuse Gastric Cancer: A Systematic Review. Cancers (Basel) 2021;13:1269. [PMID: 33809393 DOI: 10.3390/cancers13061269] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 6.0] [Reference Citation Analysis]
86 Pinto C, Cunha A, Rodrigues Â, Dias R, Brandão C, Dinis-ribeiro M. Diagnosis of MALT Lymphoma from Surveillance Endoscopy of a Patient with a <b><i>CDH1</i></b> Gene Germline Mutation. GE Port J Gastroenterol 2022;29:51-5. [DOI: 10.1159/000514652] [Reference Citation Analysis]
87 Liu Y, Calzone K, Fasaye GA, Quillin J. CDH1 variants leading to gastric cancer risk management decision-making experiences in emerging adults: 'I am not ready yet'. J Genet Couns 2021;30:1091-104. [PMID: 33655597 DOI: 10.1002/jgc4.1393] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
88 Pappas A, Tan WK, Waldock W, Richardson S, Tripathi M, Januszewicz W, Roberts G, O'Donovan M, Fitzgerald RC, di Pietro M. Single-bite versus double-bite technique for mapping biopsies during endoscopic surveillance for hereditary diffuse gastric cancer: a single-center, randomized trial. Endoscopy 2021;53:246-53. [PMID: 32679601 DOI: 10.1055/a-1201-3125] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
89 Zhu H, Shan Y, Ge K, Lu J, Kong W, Jia C. EIF3B promotes cancer progression in pancreatic cancer. Scand J Gastroenterol 2021;56:281-8. [PMID: 33459066 DOI: 10.1080/00365521.2020.1868566] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
90 Catanese S, Lordick F. Targeted and immunotherapy in the era of personalised gastric cancer treatment. Best Pract Res Clin Gastroenterol 2021;50-51:101738. [PMID: 33975679 DOI: 10.1016/j.bpg.2021.101738] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
91 Tacheci I, Repak R, Podhola M, Benesova L, Cyrany J, Bures J, Kohoutova D. Gastric adenocarcinoma and proximal polyposis of the stomach (GAPPS) - A Helicobacter-opposite point. Best Pract Res Clin Gastroenterol 2021;50-51:101728. [PMID: 33975682 DOI: 10.1016/j.bpg.2021.101728] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
92 Vos EL, Salo-Mullen EE, Tang LH, Schattner M, Yoon SS, Gerdes H, Markowitz AJ, Mandelker D, Janjigian Y, Offitt K, Coit DG, Stadler ZK, Strong VE. Indications for Total Gastrectomy in CDH1 Mutation Carriers and Outcomes of Risk-Reducing Minimally Invasive and Open Gastrectomies. JAMA Surg 2020;155:1050-7. [PMID: 32997132 DOI: 10.1001/jamasurg.2020.3356] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 7.5] [Reference Citation Analysis]
93 Rasmussen SA, Arnason T, Huang WY. Deep learning for computer-assisted diagnosis of hereditary diffuse gastric cancer. J Pathol Transl Med 2021;55:118-24. [PMID: 33472333 DOI: 10.4132/jptm.2020.12.22] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
94 Namikawa K, Kawachi H, Tsugeno Y, Nakajima T, Fujisaki J. Detection of multiple intramucosal signet-ring cell carcinomas by white-light endoscopy and magnifying endoscopy with narrow-band imaging in a hereditary diffuse gastric cancer patient with a CDH1 germline mutation. VideoGIE 2021;6:163-6. [PMID: 33898891 DOI: 10.1016/j.vgie.2020.11.020] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
95 Singh J, Kumar P, Verma K, Tiwary SK, Narayan G, Dixit VK. Molecular genetic changes in gastric carcinoma. IJMIO 2021;6:30-46. [DOI: 10.25259/ijmio_8_2020] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
96 Bylstra Y, Lim WK, Kam S, Tham KW, Wu RR, Teo JX, Davila S, Kuan JL, Chan SH, Bertin N, Yang CX, Rozen S, Teh BT, Yeo KK, Cook SA, Jamuar SS, Ginsburg GS, Orlando LA, Tan P. Family history assessment significantly enhances delivery of precision medicine in the genomics era. Genome Med 2021;13:3. [PMID: 33413596 DOI: 10.1186/s13073-020-00819-1] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
97 Dilek FH, Kahraman DİA. Histopathological Findings in Prophylactic Surgical Specimens. Prophylactic Surgery 2021. [DOI: 10.1007/978-3-030-66853-2_26] [Reference Citation Analysis]
98 Menendez C, Marcom PK, Sutton LM. Hereditary Cancer Counseling and Germline Genetic Testing. Common Issues in Breast Cancer Survivors 2021. [DOI: 10.1007/978-3-030-75377-1_20] [Reference Citation Analysis]
99 Naghi Vishteh M, Salmani TA, Javadi Mamaghani A, Seyyed Tabaei SJ, Kheirollahi M. Novel somatic variants in CTNNA1 gene in Iranian patients with diffuse gastric cancer. Gastroenterol Hepatol Bed Bench 2021;14:17-24. [PMID: 33868605] [Reference Citation Analysis]
100 Miyashita M, Ishida T. Hereditary Breast Cancer. Hereditary Breast and Ovarian Cancer 2021. [DOI: 10.1007/978-981-16-4521-1_6] [Reference Citation Analysis]
101 Acar N, Dilek ON. The Place of Prophylactic Surgery in Guidelines. Prophylactic Surgery 2021. [DOI: 10.1007/978-3-030-66853-2_40] [Reference Citation Analysis]
102 Özsoy M, Yaylak F. Stomach and Duodenum Resections for Genetic Predispositions. Prophylactic Surgery 2021. [DOI: 10.1007/978-3-030-66853-2_14] [Reference Citation Analysis]
103 Gullo I, Oliveira C, van der Post RS, van Dieren JM, Davis JL, Bougen-zhukov N, Guilford P, Carneiro F. Updated perspective and directions on hereditary diffuse gastric cancer. Research and Clinical Applications of Targeting Gastric Neoplasms 2021. [DOI: 10.1016/b978-0-323-85563-1.00011-3] [Reference Citation Analysis]
104 Dings MP, Vermeulen L, Bijlsma MF. Systems biology and molecular characterization of subtypes to guide targeted therapies in gastric cancer. Research and Clinical Applications of Targeting Gastric Neoplasms 2021. [DOI: 10.1016/b978-0-323-85563-1.00001-0] [Reference Citation Analysis]
105 Schönbuchner I, Weber BHF. Humangenetische Beratung und DNA-Diagnostik bei gynäkologischen Tumoren. Die Gynäkologie 2021. [DOI: 10.1007/978-3-662-47329-0_42-1] [Reference Citation Analysis]
106 Aretz S, Hüneburg R. Erbliche Tumorsyndrome des Gastrointestinaltrakts. Therapie-Handbuch - Gastroenterologie und Hepatologie 2021. [DOI: 10.1016/b978-3-437-23847-5.00031-4] [Reference Citation Analysis]
107 Friedman M, Adar T, Patel D, Lauwers GY, Yoon SS, Mullen JT, Chung DC. Surveillance Endoscopy in the Management of Hereditary Diffuse Gastric Cancer Syndrome. Clin Gastroenterol Hepatol 2021;19:189-91. [PMID: 31678201 DOI: 10.1016/j.cgh.2019.10.033] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
108 Charames GS, Sabatini P, Watkins N. Clinical and genetic evidence and population evidence. Clinical DNA Variant Interpretation 2021. [DOI: 10.1016/b978-0-12-820519-8.00021-1] [Reference Citation Analysis]
109 Gullo I, van der Post RS, Carneiro F. Recent advances in the pathology of heritable gastric cancer syndromes. Histopathology 2021;78:125-47. [PMID: 33382491 DOI: 10.1111/his.14228] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 3.7] [Reference Citation Analysis]
110 Marwitz T, Hüneburg R, Spier I, Lau JF, Kristiansen G, Lingohr P, Kalff JC, Aretz S, Nattermann J, Strassburg CP. Hereditary Diffuse Gastric Cancer: A Comparative Cohort Study According to Pathogenic Variant Status. Cancers (Basel) 2020;12:E3726. [PMID: 33322525 DOI: 10.3390/cancers12123726] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
111 Buran T, Şahin M. Mide Kanseri’nde Erken Tanı Hayat Kurtarır. Celal Bayar Üniversitesi Sağlık Bilimleri Enstitüsü Dergisi 2020. [DOI: 10.34087/cbusbed.783811] [Reference Citation Analysis]
112 El Rami FE, Barsoumian HB, Khneizer GW. Hereditary diffuse gastric cancer therapeutic roadmap: current and novel approaches in a nutshell. Ther Adv Med Oncol 2020;12:1758835920967238. [PMID: 33193828 DOI: 10.1177/1758835920967238] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
113 Hirakawa M, Takada K, Sato M, Fujita C, Hayasaka N, Nobuoka T, Sugita S, Ishikawa A, Mizukami M, Ohnuma H, Murase K, Miyanishi K, Kobune M, Takemasa I, Hasegawa T, Sakurai A, Kato J. Case series of three patients with hereditary diffuse gastric cancer in a single family: Three case reports and review of literature. World J Gastroenterol 2020; 26(42): 6689-6697 [PMID: 33268956 DOI: 10.3748/wjg.v26.i42.6689] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
114 Diaz LI, Mony S, Klapman J. Narrative review of the role of gastroenterologist in the diagnosis, treatment and palliation in gastric and gastroesophageal cancer. Ann Transl Med 2020;8:1106. [PMID: 33145325 DOI: 10.21037/atm-20-4143] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
115 Richard N, Sefrioui D, Di Fiore F, Michel P. Cáncer de estómago. EMC - Tratado de Medicina 2020;24:1-7. [DOI: 10.1016/s1636-5410(20)44312-0] [Reference Citation Analysis]
116 Djanani A. Familiäre gastrointestinale Tumorerkrankungen: daran denken! J Gastroenterol Hepatol Erkr 2020;18:95-101. [DOI: 10.1007/s41971-020-00085-3] [Reference Citation Analysis]
117 Yang K, Lu L, Liu H, Wang X, Gao Y, Yang L, Li Y, Su M, Jin M, Khan S. A comprehensive update on early gastric cancer: defining terms, etiology, and alarming risk factors. Expert Rev Gastroenterol Hepatol 2021;15:255-73. [PMID: 33121300 DOI: 10.1080/17474124.2021.1845140] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
118 Yang B, Zhang M, Luo T. Identification of Potential Core Genes Associated With the Progression of Stomach Adenocarcinoma Using Bioinformatic Analysis. Front Genet 2020;11:517362. [PMID: 33193601 DOI: 10.3389/fgene.2020.517362] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
119 Tsugeno Y, Nakano K, Nakajima T, Namikawa K, Takamatsu M, Yamamoto N, Fujisaki J, Nunobe S, Kitagawa M, Takeuchi K, Kawachi H. Histopathologic Analysis of Signet-ring Cell Carcinoma In Situ in Patients With Hereditary Diffuse Gastric Cancer. Am J Surg Pathol 2020;44:1204-12. [PMID: 32520759 DOI: 10.1097/PAS.0000000000001511] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.7] [Reference Citation Analysis]
120 Smyth EC, Nilsson M, Grabsch HI, van Grieken NC, Lordick F. Gastric cancer. Lancet. 2020;396:635-648. [PMID: 32861308 DOI: 10.1016/s0140-6736(20)31288-5] [Cited by in Crossref: 788] [Cited by in F6Publishing: 650] [Article Influence: 262.7] [Reference Citation Analysis]
121 Iyer P, Moslim M, Farma JM, Denlinger CS. Diffuse gastric cancer: histologic, molecular, and genetic basis of disease. Transl Gastroenterol Hepatol 2020;5:52. [PMID: 33073047 DOI: 10.21037/tgh.2020.01.02] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
122 van Dieren JM, Kodach LL, den Hartog P, van der Kolk LE, Sikorska K, van Velthuysen MF, van Sandick JW, Koemans WJ, Snaebjornsson P, Cats A. Gastroscopic surveillance with targeted biopsies compared with random biopsies in CDH1 mutation carriers. Endoscopy 2020;52:839-46. [PMID: 32408363 DOI: 10.1055/a-1157-8678] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 5.3] [Reference Citation Analysis]
123 Ginsburg O, Ashton-Prolla P, Cantor A, Mariosa D, Brennan P. The role of genomics in global cancer prevention. Nat Rev Clin Oncol 2021;18:116-28. [PMID: 32973296 DOI: 10.1038/s41571-020-0428-5] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 5.0] [Reference Citation Analysis]
124 Katona BW, Clark DF, Domchek SM. CDH1 on Multigene Panel Testing: Look Before You Leap. J Natl Cancer Inst 2020;112:330-4. [PMID: 31841163 DOI: 10.1093/jnci/djz229] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 5.7] [Reference Citation Analysis]
125 Goud HK, Mehkari Z, Mohammed L, Javed M, Althwanay A, Ahsan F, Oliveri F, Rutkofsky IH. Significance of E-cadherin Gene Mutations in Patients With Hereditary Diffuse Gastric Cancer Syndrome: A Systematic Review. Cureus 2020;12:e10406. [PMID: 33062523 DOI: 10.7759/cureus.10406] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
126 Martínez Valenzuela C, Castelán-Maldonado EE, Carvajal-Zarrabal O, Calderón-Garcidueñas AL. First report of a Mexican family with mutation in the CDH1 gene. Mol Genet Genomic Med 2020;8:e1208. [PMID: 32886433 DOI: 10.1002/mgg3.1208] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
127 Kobiyama R, Okumura T, Hirano K, Watanabe T, Shibuya K, Hojo S, Matsui K, Yoshioka I, Nagata T, Hayashi S, Fujii T. A Surgical Case of Multiple Gastric Cancers on the Background of Nodular Gastritis in a Twelve-Year-Old Child. Jpn J Gastroenterol Surg, Nihon Shokaki Geka Gakkai zasshi 2020;53:693-700. [DOI: 10.5833/jjgs.2019.0123] [Reference Citation Analysis]
128 Malik S, Semrad CE. Nutritional Implications in Preparing Patients for Total Gastrectomy. Curr Surg Rep 2020;8. [DOI: 10.1007/s40137-020-00273-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
129 Blair VR, McLeod M, Carneiro F, Coit DG, D'Addario JL, van Dieren JM, Harris KL, Hoogerbrugge N, Oliveira C, van der Post RS, Arnold J, Benusiglio PR, Bisseling TM, Boussioutas A, Cats A, Charlton A, Schreiber KEC, Davis JL, Pietro MD, Fitzgerald RC, Ford JM, Gamet K, Gullo I, Hardwick RH, Huntsman DG, Kaurah P, Kupfer SS, Latchford A, Mansfield PF, Nakajima T, Parry S, Rossaak J, Sugimura H, Svrcek M, Tischkowitz M, Ushijima T, Yamada H, Yang HK, Claydon A, Figueiredo J, Paringatai K, Seruca R, Bougen-Zhukov N, Brew T, Busija S, Carneiro P, DeGregorio L, Fisher H, Gardner E, Godwin TD, Holm KN, Humar B, Lintott CJ, Monroe EC, Muller MD, Norero E, Nouri Y, Paredes J, Sanches JM, Schulpen E, Ribeiro AS, Sporle A, Whitworth J, Zhang L, Reeve AE, Guilford P. Hereditary diffuse gastric cancer: updated clinical practice guidelines. Lancet Oncol 2020;21:e386-97. [PMID: 32758476 DOI: 10.1016/S1470-2045(20)30219-9] [Cited by in Crossref: 109] [Cited by in F6Publishing: 91] [Article Influence: 36.3] [Reference Citation Analysis]
130 Hu MN, Hu SH, Zhang XW, Xiong SM, Deng H. Overview on new progress of hereditary diffuse gastric cancer with CDH1 variants. Tumori 2020;106:346-55. [PMID: 32811340 DOI: 10.1177/0300891620949668] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
131 Sánchez Fuentes PA, Vidaña Márquez E, Velasco Albendea FJ. Hereditary diffuse CDH1 positive gastric cancer. Prophylactic gastrectomy? Med Clin (Barc) 2021;157:46-8. [PMID: 32773164 DOI: 10.1016/j.medcli.2020.04.064] [Reference Citation Analysis]
132 McGarragle KM, Hart TL, Swallow C, Brar S, Govindarajan A, Cohen Z, Aronson M. Barriers and facilitators to CDH1 carriers contemplating or undergoing prophylactic total gastrectomy. Fam Cancer 2021;20:157-69. [PMID: 32754788 DOI: 10.1007/s10689-020-00197-y] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
133 Forman A, Sotelo J. Tumor-Based Genetic Testing and Familial Cancer Risk. Cold Spring Harb Perspect Med 2020;10:a036590. [PMID: 31570381 DOI: 10.1101/cshperspect.a036590] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 4.7] [Reference Citation Analysis]
134 Devezas V, Baptista M, Gullo I, Rocha J, Sousa F, Xiaogang W, Preto J, Costa S, Castedo S, Garrido L, Oliveira C, Barbosa E, Carneiro F, Barbosa J. Risk-reducing total gastrectomy in asymptomatic CDH1 carriers. Eur Surg 2020;52:171-178. [DOI: 10.1007/s10353-020-00630-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
135 Stjepanovic N, Moreira L, Carneiro F, Balaguer F, Cervantes A, Balmaña J, Martinelli E; ESMO Guidelines Committee. Electronic address: clinicalguidelines@esmo.org. Hereditary gastrointestinal cancers: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up†. Ann Oncol 2019;30:1558-71. [PMID: 31378807 DOI: 10.1093/annonc/mdz233] [Cited by in Crossref: 73] [Cited by in F6Publishing: 58] [Article Influence: 24.3] [Reference Citation Analysis]
136 Canale M, Casadei-Gardini A, Ulivi P, Arechederra M, Berasain C, Lollini PL, Fernández-Barrena MG, Avila MA. Epigenetic Mechanisms in Gastric Cancer: Potential New Therapeutic Opportunities. Int J Mol Sci 2020;21:E5500. [PMID: 32752096 DOI: 10.3390/ijms21155500] [Cited by in Crossref: 6] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
137 Waddingham W, Nieuwenburg SAV, Carlson S, Rodriguez-Justo M, Spaander M, Kuipers EJ, Jansen M, Graham DG, Banks M. Recent advances in the detection and management of early gastric cancer and its precursors. Frontline Gastroenterol 2021;12:322-31. [PMID: 34249318 DOI: 10.1136/flgastro-2018-101089] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 4.3] [Reference Citation Analysis]
138 Peleg Hasson S, Menes T, Sonnenblick A. Comparison of Patient Susceptibility Genes Across Breast Cancer: Implications for Prognosis and Therapeutic Outcomes. Pharmgenomics Pers Med 2020;13:227-38. [PMID: 32801835 DOI: 10.2147/PGPM.S233485] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
139 Caggiari L, Fornasarig M, De Zorzi M, Cannizzaro R, Steffan A, De Re V. Family's History Based on the CDH1 Germline Variant (c.360delG) and a Suspected Hereditary Gastric Cancer Form. Int J Mol Sci 2020;21:E4904. [PMID: 32664545 DOI: 10.3390/ijms21144904] [Reference Citation Analysis]
140 Iwaizumi M, Yamada H, Fukue M, Maruyama Y, Sonoda A, Sugimoto M, Koda K, Kushima R, Maekawa M, Sugimura H. Two independent families with strongly suspected hereditary diffuse gastric cancer based on the probands' endoscopic findings. Clin J Gastroenterol. 2020;13:754-758. [PMID: 32594425 DOI: 10.1007/s12328-020-01163-y] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
141 Villy MC, Mouret-Fourme E, Golmard L, Becette V, Callet N, Marx G, Colas C, Lamarque D, Rouleau E, Stoppa-Lyonnet D. Co-occurrence of germline BRCA1 and CDH1 pathogenic variants. J Med Genet 2021;58:357-61. [PMID: 32576655 DOI: 10.1136/jmedgenet-2020-106972] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
142 Corso G, Montagna G, Figueiredo J, La Vecchia C, Fumagalli Romario U, Fernandes MS, Seixas S, Roviello F, Trovato C, Guerini-Rocco E, Fusco N, Pravettoni G, Petrocchi S, Rotili A, Massari G, Magnoni F, De Lorenzi F, Bottoni M, Galimberti V, Sanches JM, Calvello M, Seruca R, Bonanni B. Hereditary Gastric and Breast Cancer Syndromes Related to CDH1 Germline Mutation: A Multidisciplinary Clinical Review. Cancers (Basel) 2020;12:E1598. [PMID: 32560361 DOI: 10.3390/cancers12061598] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 5.3] [Reference Citation Analysis]
143 Xiang P, Sun Y, Fang Z, Yan K, Fan Y. Eukaryotic translation initiation factor 3 subunit b is a novel oncogenic factor in prostate cancer. Mamm Genome 2020;31:197-204. [PMID: 32556998 DOI: 10.1007/s00335-020-09842-4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
144 Leclercq P, Jadot V, Bours V, Oliveira C, Neumann H, Bisschops R. Inherited CDH1 pathogenic variant: is there a place for surveillance of esophageal gastric inlet patch? Therap Adv Gastroenterol 2020;13:1756284820916399. [PMID: 32523621 DOI: 10.1177/1756284820916399] [Reference Citation Analysis]
145 Benesch MGK, Mathieson A. Epidemiology of Signet Ring Cell Adenocarcinomas. Cancers (Basel) 2020;12:E1544. [PMID: 32545410 DOI: 10.3390/cancers12061544] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 5.0] [Reference Citation Analysis]
146 Samola Winnberg J, Rudd E, Keränen A, Lagerstedt-Robinson K, Lindblom A, Nilsson M, Lindblad M, Sjödahl K. Increased risk for uterine cancer among first-degree relatives to Swedish gastric cancer patients. Hered Cancer Clin Pract 2020;18:12. [PMID: 32518610 DOI: 10.1186/s13053-020-00145-y] [Reference Citation Analysis]
147 Van Dieren JM, Kodach LL, Cats A. Targeted vs Random Biopsies in Surveillance Endoscopy in Hereditary Diffuse Gastric Cancer Syndrome. Clin Gastroenterol Hepatol 2020;18:1647-8. [PMID: 31887448 DOI: 10.1016/j.cgh.2019.12.022] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
148 Balmagambetova SK, Bekmukhambetov YZ, Tulyaeva AB, Iztleuov YM, Smagulova GA, Koyshybaev AK, Urazayev ON, Djussembekov ST, Begunov VV, Kokhreidze I. Gastric Cancer in Aktobe Region of Western Kazakhstan from 2009 to 2018: Incidence Rates, Trends, and Five-Year Survival. Asian Pac J Cancer Prev 2020;21:1645-52. [PMID: 32592359 DOI: 10.31557/APJCP.2020.21.6.1645] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
149 Corso G. Letter Regarding: Is Prophylactic Total Gastrectomy Always Indicated in CDH1 Germline Mutant Carriers? J Surg Res 2020;255:647-8. [PMID: 32439144 DOI: 10.1016/j.jss.2020.02.022] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
150 Januszewicz W, Kaminski MF. Quality indicators in diagnostic upper gastrointestinal endoscopy. Therap Adv Gastroenterol 2020;13:1756284820916693. [PMID: 32477426 DOI: 10.1177/1756284820916693] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 4.7] [Reference Citation Analysis]
151 Suzuki A, Katoh H, Komura D, Kakiuchi M, Tagashira A, Yamamoto S, Tatsuno K, Ueda H, Nagae G, Fukuda S, Umeda T, Totoki Y, Abe H, Ushiku T, Matsuura T, Sakai E, Ohshima T, Nomura S, Seto Y, Shibata T, Rino Y, Nakajima A, Fukayama M, Ishikawa S, Aburatani H. Defined lifestyle and germline factors predispose Asian populations to gastric cancer. Sci Adv. 2020;6:eaav9778. [PMID: 32426482 DOI: 10.1126/sciadv.aav9778] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 7.0] [Reference Citation Analysis]
152 Niemeyer E, Mofid H, Zornig C, Burandt EC, Stein A, Block A, Volk AE. Case report: acute abdominal pain in a 37-year-old patient and the consequences for his family. BMC Gastroenterol 2020;20:129. [PMID: 32362280 DOI: 10.1186/s12876-020-01283-2] [Reference Citation Analysis]
153 Aronson M, Swallow C, Govindarajan A, Semotiuk K, Cohen Z, Kaurah P, Velsher L, Ambus I, Buckley K, Forster-Gibson C, Meschino WS, Blumenthal A, Kim RH, Brar S. Germline variants and phenotypic spectrum in a Canadian cohort of individuals with diffuse gastric cancer. Curr Oncol 2020;27:e182-90. [PMID: 32489267 DOI: 10.3747/co.27.5663] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
154 Therkildsen C, Rasmussen M, Smith-Hansen L, Kallemose T, Lindberg LJ, Nilbert M. Broadening risk profile in familial colorectal cancer type X; increased risk for five cancer types in the national Danish cohort. BMC Cancer 2020;20:345. [PMID: 32321466 DOI: 10.1186/s12885-020-06859-5] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
155 LeBlanc S, Naveen D, Haan E, Barnett C, Rawlings L, Roscioli T, Poplawski N. CDH1-related blepharocheilodontic syndrome is associated with diffuse gastric cancer risk. Am J Med Genet A 2020;182:1780-4. [PMID: 32302040 DOI: 10.1002/ajmg.a.61601] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
156 Wang SC, Yeu Y, Hammer STG, Xiao S, Zhu M, Hong C, Clemenceau JR, Yoon LY, Nassour I, Shen J, Agarwal D, Reznik SI, Mansour JC, Yopp AC, Zhu H, Hwang TH, Porembka MR. Hispanic/Latino Patients with Gastric Adenocarcinoma Have Distinct Molecular Profiles Including a High Rate of Germline CDH1 Variants. Cancer Res 2020;80:2114-24. [PMID: 32269045 DOI: 10.1158/0008-5472.CAN-19-2918] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 4.3] [Reference Citation Analysis]
157 Laszkowska M, Silver ER, Schrope B, Kastrinos F, Wang TC, Hur C. Optimal Timing of Total Gastrectomy to Prevent Diffuse Gastric Cancer in Individuals With Pathogenic Variants in CDH1. Clin Gastroenterol Hepatol 2020;18:822-829.e4. [PMID: 31220641 DOI: 10.1016/j.cgh.2019.06.009] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.7] [Reference Citation Analysis]
158 Ebrahimzadeh JE, Long JM, Wang L, Nathanson JT, Siddique SM, Rustgi AK, Goldberg DS, Katona BW. Associations of sociodemographic and clinical factors with gastrointestinal cancer risk assessment appointment completion. J Genet Couns 2020;29:616-24. [PMID: 32227561 DOI: 10.1002/jgc4.1254] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
159 Li S, Rexin P, Qin Z, Changbo C, Guanghui C, Luyao W, Voelker HU, Stauch G. Different Incidence of Early-Onset Gastric Carcinoma Depending on Ethnicity: Preliminary Results of a Hospital in Liangshan. ScientificWorldJournal 2020;2020:6845413. [PMID: 32231466 DOI: 10.1155/2020/6845413] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
160 Renaud F, Svrcek M. [Hereditary gastric cancer: Challenges for the pathologist in 2020]. Ann Pathol 2020;40:95-104. [PMID: 32147190 DOI: 10.1016/j.annpat.2020.02.007] [Reference Citation Analysis]
161 Muro K, Van Cutsem E, Narita Y, Pentheroudakis G, Baba E, Li J, Ryu MH, Zamaniah WIW, Yong WP, Yeh KH, Kato K, Lu Z, Cho BC, Nor IM, Ng M, Chen LT, Nakajima TE, Shitara K, Kawakami H, Tsushima T, Yoshino T, Lordick F, Martinelli E, Smyth EC, Arnold D, Minami H, Tabernero J, Douillard JY. Pan-Asian adapted ESMO Clinical Practice Guidelines for the management of patients with metastatic gastric cancer: a JSMO-ESMO initiative endorsed by CSCO, KSMO, MOS, SSO and TOS. Ann Oncol. 2019;30:19-33. [PMID: 30475956 DOI: 10.1093/annonc/mdy502] [Cited by in Crossref: 116] [Cited by in F6Publishing: 121] [Article Influence: 38.7] [Reference Citation Analysis]
162 Dibrito SR, Blair AB, Prasath V, Habibi M, Harmon JW, Duncan MD. Total Gastrectomy for CDH-1 Mutation Carriers: An Institutional Experience. Journal of Surgical Research 2020;247:438-44. [DOI: 10.1016/j.jss.2019.09.062] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
163 Kaurah P, Talhouk A, MacMillan A, Lewis I, Chelcun-Schreiber K, Yoon SS, Huntsman D. Hereditary diffuse gastric cancer: cancer risk and the personal cost of preventive surgery. Fam Cancer 2019;18:429-38. [PMID: 31273560 DOI: 10.1007/s10689-019-00133-9] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 5.3] [Reference Citation Analysis]
164 Biagioni A, Skalamera I, Peri S, Schiavone N, Cianchi F, Giommoni E, Magnelli L, Papucci L. Update on gastric cancer treatments and gene therapies. Cancer Metastasis Rev 2019;38:537-48. [PMID: 31486976 DOI: 10.1007/s10555-019-09803-7] [Cited by in Crossref: 72] [Cited by in F6Publishing: 68] [Article Influence: 24.0] [Reference Citation Analysis]
165 Basset N, Desseignés C, Boucher C, Coulet F, Benusiglio PR. [Clinical Cancer Genetics: A guide for the pathologist]. Ann Pathol 2020;40:63-9. [PMID: 32046877 DOI: 10.1016/j.annpat.2020.01.003] [Reference Citation Analysis]
166 Angeli D, Salvi S, Tedaldi G. Genetic Predisposition to Breast and Ovarian Cancers: How Many and Which Genes to Test? Int J Mol Sci 2020;21:E1128. [PMID: 32046255 DOI: 10.3390/ijms21031128] [Cited by in Crossref: 33] [Cited by in F6Publishing: 33] [Article Influence: 11.0] [Reference Citation Analysis]
167 Kumar S, Katona BW, Long JM, Domchek S, Rustgi AK, Roses R, Ginsberg GG. Endoscopic Ultrasound Has Limited Utility in Diagnosis of Gastric Cancer in Carriers of CDH1 Mutations. Clin Gastroenterol Hepatol 2020;18:505-508.e1. [PMID: 31077828 DOI: 10.1016/j.cgh.2019.04.064] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 3.7] [Reference Citation Analysis]
168 Bylstra Y, Lim WK, Kam S, Tham KW, Wu RR, Teo JX, Davila S, Kuan JL, Chan SH, Bertin N, Yang C, Rozen S, Teh BT, Yeo KK, Cook SA, Orlando LA, Jamuar SS, Ginsburg GS, Tan P. Family History Assessment Significantly Enhances Delivery of Precision Medicine in the Genomics Era.. [DOI: 10.1101/2020.01.29.926139] [Reference Citation Analysis]
169 Moridnia A, Tabatabaiefar MA, Zeinalian M, Minakari M, Kheirollahi M, Moghaddam NA. Novel Variants and Copy Number Variation in CDH1 Gene in Iranian Patients with Sporadic Diffuse Gastric Cancer. J Gastrointest Cancer 2019;50:420-7. [PMID: 29577179 DOI: 10.1007/s12029-018-0082-7] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
170 Zhang Q, Yang Z, Karamchandani DM. Complete histopathologic examination of risk reduction gastrectomy specimens for CDH1 germline mutation: Is it warranted in routine clinical practice? Ann Diagn Pathol 2020;45:151473. [PMID: 31986421 DOI: 10.1016/j.anndiagpath.2020.151473] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
171 Leja M, Chapelle N, Kikuste I, Fedorov E, Sivins A, Carneiro F, Matysiak-budnik T. Gastric Cancer; Prevention and Treatment. Encyclopedia of Gastroenterology 2020. [DOI: 10.1016/b978-0-12-801238-3.11317-0] [Reference Citation Analysis]
172 Shin S, Kim Y, Lee JK, Lee KA. Frequency and Clinical Characteristics of Unselected Korean Gastric Cancer Patients with a Germline CDH1 V832M Mutation. J Cancer 2020;11:208-12. [PMID: 31892987 DOI: 10.7150/jca.36513] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
173 Khorasani M, Brar SS, Coburn NG. Gastric Adenocarcinoma. Surgical Oncology Manual 2020. [DOI: 10.1007/978-3-030-48363-0_11] [Reference Citation Analysis]
174 Bornschein J, Quante M, Fassan M. Gastric Cancer; Epidemiology and Diagnosis. Encyclopedia of Gastroenterology 2020. [DOI: 10.1016/b978-0-12-801238-3.65678-7] [Reference Citation Analysis]
175 Rädle J. Hereditäre Tumorerkrankungen – Diagnostik und Überwachungsstrategien. Prävention gastroenterologischer Tumorerkrankungen 2020. [DOI: 10.1007/978-3-662-58879-6_9] [Reference Citation Analysis]
176 Weiss J, Zakas A, Hause J. Gastrointestinal disorders. Handbook of Clinical Adult Genetics and Genomics 2020. [DOI: 10.1016/b978-0-12-817344-2.00013-7] [Reference Citation Analysis]
177 Clauditz TS, Moore M, Setia N, Kumarasinghe M, Lauwers GY. Syndromic gastric polyposis and hereditary gastric cancers. Diagnostic Histopathology 2020;26:39-46. [DOI: 10.1016/j.mpdhp.2019.10.013] [Reference Citation Analysis]
178 Walsh MF, Cadoo K, Salo-mullen EE, Dubard-gault M, Stadler ZK, Offit K. Genetic Factors. Abeloff's Clinical Oncology 2020. [DOI: 10.1016/b978-0-323-47674-4.00013-x] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
179 Shenoy S. CDH1 (E-Cadherin) Mutation and Gastric Cancer: Genetics, Molecular Mechanisms and Guidelines for Management. Cancer Manag Res 2019;11:10477-86. [PMID: 31853199 DOI: 10.2147/CMAR.S208818] [Cited by in Crossref: 43] [Cited by in F6Publishing: 46] [Article Influence: 10.8] [Reference Citation Analysis]
180 Lim JH. How to Apply Genetic Analysis for Hereditary Diffuse Gastric Cancer? Korean J Helicobacter Up Gastrointest Res 2019;19:289-290. [DOI: 10.7704/kjhugr.2019.0029] [Reference Citation Analysis]
181 van der Post RS, Oliveira C, Guilford P, Carneiro F. Hereditary gastric cancer: what's new? Update 2013-2018. Fam Cancer. 2019;18:363-367. [PMID: 30989426 DOI: 10.1007/s10689-019-00127-7] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 6.5] [Reference Citation Analysis]
182 . Hereditary Cancer Syndromes and Risk Assessment: ACOG COMMITTEE OPINION, Number 793. Obstetrics & Gynecology 2019;134:e143-9. [DOI: 10.1097/aog.0000000000003562] [Cited by in Crossref: 28] [Cited by in F6Publishing: 29] [Article Influence: 7.0] [Reference Citation Analysis]
183 Ye DM, Xu G, Ma W, Li Y, Luo W, Xiao Y, Liu Y, Zhang Z. Significant function and research progress of biomarkers in gastric cancer. Oncol Lett 2020;19:17-29. [PMID: 31897111 DOI: 10.3892/ol.2019.11078] [Cited by in Crossref: 9] [Cited by in F6Publishing: 14] [Article Influence: 2.3] [Reference Citation Analysis]
184 Grady MC, Kolla KA, Peshkin BN. Multigene Cancer Panels: Implications for Pre- and Post-test Genetic Counseling. Curr Genet Med Rep 2019;7:169-79. [DOI: 10.1007/s40142-019-00173-8] [Reference Citation Analysis]
185 Vogelsang HE. Prophylactic Surgery and Extended Oncologic Radicality in Gastric and Colorectal Hereditary Cancer Syndromes. Visc Med 2019;35:231-9. [PMID: 31602384 DOI: 10.1159/000501919] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
186 Norero E, Alarcon MA, Hakkaart C, de Mayo T, Mellado C, Garrido M, Aguayo G, Lagos M, Torres J, Calvo A, Guilford P, Corvalan AH. Identification of c.1531C>T Pathogenic Variant in the CDH1 Gene as a Novel Germline Mutation of Hereditary Diffuse Gastric Cancer. Int J Mol Sci 2019;20:E4980. [PMID: 31600923 DOI: 10.3390/ijms20204980] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 2.3] [Reference Citation Analysis]
187 Catherine Framp A, McAllister M, Dwyer T. Narrative research methods with vulnerable people: sharing insights. Nurse Res 2019;27:42-7. [PMID: 31802652 DOI: 10.7748/nr.2019.e1671] [Reference Citation Analysis]
188 Ramos MFKP, Pereira MA, Sagae VMT, Mester M, Morrell ALG, Dias AR, Zilberstein B, Ribeiro Junior U, Cecconello I. Gastric cancer in young adults: a worse prognosis group? Rev Col Bras Cir 2019;46:e20192256. [PMID: 31576989 DOI: 10.1590/0100-6991e-20192256] [Cited by in Crossref: 9] [Cited by in F6Publishing: 12] [Article Influence: 2.3] [Reference Citation Analysis]
189 Gianella CA, Bendito B, Iglesias C, Bengoechea MP, Miñón C, Ruiz A. Risk-reducing mastectomy in germline CDH1 mutation carriers: Pathologic findings. Breast J 2020;26:583-4. [PMID: 31538378 DOI: 10.1111/tbj.13604] [Reference Citation Analysis]
190 Bougen-Zhukov N, Nouri Y, Godwin T, Taylor M, Hakkaart C, Single A, Brew T, Permina E, Chen A, Black MA, Guilford P. Allosteric AKT Inhibitors Target Synthetic Lethal Vulnerabilities in E-Cadherin-Deficient Cells. Cancers (Basel) 2019;11:E1359. [PMID: 31540244 DOI: 10.3390/cancers11091359] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 4.0] [Reference Citation Analysis]
191 Tedaldi G, Pirini F, Tebaldi M, Zampiga V, Cangini I, Danesi R, Arcangeli V, Ravegnani M, Abou Khouzam R, Molinari C, Oliveira C, Morgagni P, Saragoni L, Bencivenga M, Ulivi P, Amadori D, Martinelli G, Falcini F, Ranzani GN, Calistri D. Multigene Panel Testing Increases the Number of Loci Associated with Gastric Cancer Predisposition. Cancers (Basel) 2019;11:E1340. [PMID: 31514334 DOI: 10.3390/cancers11091340] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 3.8] [Reference Citation Analysis]
192 Katabathina VS, Menias CO, Khanna L, Murphy L, Dasyam AK, Lubner MG, Prasad SR. Hereditary Gastrointestinal Cancer Syndromes: Role of Imaging in Screening, Diagnosis, and Management. RadioGraphics 2019;39:1280-301. [DOI: 10.1148/rg.2019180185] [Cited by in Crossref: 14] [Cited by in F6Publishing: 17] [Article Influence: 3.5] [Reference Citation Analysis]
193 Banks M, Graham D, Jansen M, Gotoda T, Coda S, di Pietro M, Uedo N, Bhandari P, Pritchard DM, Kuipers EJ, Rodriguez-Justo M, Novelli MR, Ragunath K, Shepherd N, Dinis-Ribeiro M. British Society of Gastroenterology guidelines on the diagnosis and management of patients at risk of gastric adenocarcinoma. Gut 2019;68:1545-75. [PMID: 31278206 DOI: 10.1136/gutjnl-2018-318126] [Cited by in Crossref: 203] [Cited by in F6Publishing: 184] [Article Influence: 50.8] [Reference Citation Analysis]
194 Roberts ME, Ranola JMO, Marshall ML, Susswein LR, Graceffo S, Bohnert K, Tsai G, Klein RT, Hruska KS, Shirts BH. Comparison of CDH1 Penetrance Estimates in Clinically Ascertained Families vs Families Ascertained for Multiple Gastric Cancers. JAMA Oncol 2019;5:1325-31. [PMID: 31246251 DOI: 10.1001/jamaoncol.2019.1208] [Cited by in Crossref: 61] [Cited by in F6Publishing: 63] [Article Influence: 15.3] [Reference Citation Analysis]
195 Beetham H, Chen A, Telford BJ, Single A, Jarman KE, Lackovic K, Luxenburger A, Guilford P. A high-throughput screen to identify novel synthetic lethal compounds for the treatment of E-cadherin-deficient cells. Sci Rep 2019;9:12511. [PMID: 31467357 DOI: 10.1038/s41598-019-48929-0] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
196 Lee K, Krempely K, Roberts ME, Anderson MJ, Carneiro F, Chao E, Dixon K, Figueiredo J, Ghosh R, Huntsman D, Kaurah P, Kesserwan C, Landrith T, Li S, Mensenkamp AR, Oliveira C, Pardo C, Pesaran T, Richardson M, Slavin TP, Spurdle AB, Trapp M, Witkowski L, Yi CS, Zhang L, Plon SE, Schrader KA, Karam R. Specifications of the ACMG/AMP variant curation guidelines for the analysis of germline CDH1 sequence variants. Hum Mutat 2018;39:1553-68. [PMID: 30311375 DOI: 10.1002/humu.23650] [Cited by in Crossref: 96] [Cited by in F6Publishing: 101] [Article Influence: 24.0] [Reference Citation Analysis]
197 Rasnic R, Brandes N, Zuk O, Linial M. Substantial batch effects in TCGA exome sequences undermine pan-cancer analysis of germline variants. BMC Cancer 2019;19:783. [PMID: 31391007 DOI: 10.1186/s12885-019-5994-5] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
198 Li S, Chung DC, Mullen JT. Screening high-risk populations for esophageal and gastric cancer. J Surg Oncol. 2019;120:831-846. [PMID: 31373005 DOI: 10.1002/jso.25656] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 3.5] [Reference Citation Analysis]
199 Dumont F, Thibaudeau E. Gastrectomie laparoscopiche, semplici o con assistenza robotica, per tumori gastrici. EMC - Tecniche Chirurgiche Addominale 2019;25:1-14. [DOI: 10.1016/s1283-0798(19)42532-1] [Reference Citation Analysis]
200 Slavin TP, Weitzel JN, Neuhausen SL, Schrader KA, Oliveira C, Karam R. Genetics of gastric cancer: what do we know about the genetic risks? Transl Gastroenterol Hepatol 2019;4:55. [PMID: 31463414 DOI: 10.21037/tgh.2019.07.02] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 3.8] [Reference Citation Analysis]
201 Corso G, Sacchini V, Pravettoni G, Veronesi P, Bonanni B. Familial lobular breast cancer: Is testing for germline CDH1 mutations necessary? Eur J Surg Oncol 2019;45:1760-1. [PMID: 31350074 DOI: 10.1016/j.ejso.2019.07.020] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
202 Ma M, Fu Y, Zhou X, Guan F, Wang Y, Li X. Functional roles of fucosylated and O-glycosylated cadherins during carcinogenesis and metastasis. Cell Signal 2019;63:109365. [PMID: 31352008 DOI: 10.1016/j.cellsig.2019.109365] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
203 Xicola RM, Li S, Rodriguez N, Reinecke P, Karam R, Speare V, Black MH, Laduca H, Llor X. Clinical features and cancer risk in families with pathogenic CDH1 variants irrespective of clinical criteria. J Med Genet 2019;56:838-43. [DOI: 10.1136/jmedgenet-2019-105991] [Cited by in Crossref: 41] [Cited by in F6Publishing: 44] [Article Influence: 10.3] [Reference Citation Analysis]
204 Vande Perre P, Imbert-bouteille M, Pujol P. Oncogenética: cánceres de mama hereditarios. EMC - Ginecología-Obstetricia 2019;55:1-14. [DOI: 10.1016/s1283-081x(19)42497-1] [Reference Citation Analysis]
205 Dumont F, Thibaudeau E. Gastrectomías laparoscópicas, simples o con asistencia robótica, por tumores gástricos. EMC - Técnicas Quirúrgicas - Aparato Digestivo 2019;35:1-14. [DOI: 10.1016/s1282-9129(19)42464-1] [Reference Citation Analysis]
206 Jacobs MF, Dust H, Koeppe E, Wong S, Mulholland M, Choi EY, Appelman H, Stoffel EM. Outcomes of Endoscopic Surveillance in Individuals With Genetic Predisposition to Hereditary Diffuse Gastric Cancer. Gastroenterology 2019;157:87-96. [PMID: 30935944 DOI: 10.1053/j.gastro.2019.03.047] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 6.8] [Reference Citation Analysis]
207 Kumar S, Long JM, Ginsberg GG, Katona BW. The role of endoscopy in the management of hereditary diffuse gastric cancer syndrome. World J Gastroenterol 2019; 25(23): 2878-2886 [PMID: 31249446 DOI: 10.3748/wjg.v25.i23.2878] [Cited by in CrossRef: 19] [Cited by in F6Publishing: 23] [Article Influence: 4.8] [Reference Citation Analysis]
208 Demeure MJ. The Role of Precision Medicine in the Diagnosis and Treatment of Patients with Rare Cancers. Cancer Treat Res 2019;178:81-108. [PMID: 31209842 DOI: 10.1007/978-3-030-16391-4_3] [Cited by in Crossref: 2] [Article Influence: 0.5] [Reference Citation Analysis]
209 Bure IV, Nemtsova MV, Zaletaev DV. Roles of E-cadherin and Noncoding RNAs in the Epithelial-mesenchymal Transition and Progression in Gastric Cancer. Int J Mol Sci 2019;20:E2870. [PMID: 31212809 DOI: 10.3390/ijms20122870] [Cited by in Crossref: 50] [Cited by in F6Publishing: 39] [Article Influence: 12.5] [Reference Citation Analysis]
210 Dominguez RL, Cherry CB, Estevez-Ordonez D, Mera R, Escamilla V, Pawlita M, Waterboer T, Wilson KT, Peek RM, Tavera G, Williams SM, Gulley ML, Emch M, Morgan DR. Geospatial analyses identify regional hot spots of diffuse gastric cancer in rural Central America. BMC Cancer 2019;19:545. [PMID: 31174492 DOI: 10.1186/s12885-019-5726-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
211 Henare KL, Parker KE, Wihongi H, Blenkiron C, Jansen R, Reid P, Findlay MP, Lawrence B, Hudson M, Print CG. Mapping a route to Indigenous engagement in cancer genomic research. The Lancet Oncology 2019;20:e327-35. [DOI: 10.1016/s1470-2045(19)30307-9] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
212 Ruff S, Curtin B, Quezado M, Heller T, Koh C, Steinberg SM, Connolly M, Hernandez JM, Davis JL. Evaluation of confocal endoscopic microscopy for detection of early-stage gastric cancer in hereditary diffuse gastric cancer (HDGC) syndrome. J Gastrointest Oncol. 2019;10:407-411. [PMID: 31183189 DOI: 10.21037/jgo.2019.01.04] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 2.5] [Reference Citation Analysis]
213 Lott PC, Carvajal-Carmona LG. Resolving gastric cancer aetiology: an update in genetic predisposition. Lancet Gastroenterol Hepatol. 2018;3:874-883. [PMID: 30507471 DOI: 10.1016/s2468-1253(18)30237-1] [Cited by in Crossref: 48] [Cited by in F6Publishing: 51] [Article Influence: 12.0] [Reference Citation Analysis]
214 Hakkaart C, Ellison-Loschmann L, Day R, Sporle A, Koea J, Harawira P, Cheng S, Gray M, Whaanga T, Pearce N, Guilford P. Germline CDH1 mutations are a significant contributor to the high frequency of early-onset diffuse gastric cancer cases in New Zealand Māori. Fam Cancer 2019;18:83-90. [PMID: 29589180 DOI: 10.1007/s10689-018-0080-8] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 5.8] [Reference Citation Analysis]
215 Lima ZS, Ghadamzadeh M, Arashloo FT, Amjad G, Ebadi MR, Younesi L. Recent advances of therapeutic targets based on the molecular signature in breast cancer: genetic mutations and implications for current treatment paradigms. J Hematol Oncol 2019;12:38. [PMID: 30975222 DOI: 10.1186/s13045-019-0725-6] [Cited by in Crossref: 43] [Cited by in F6Publishing: 48] [Article Influence: 10.8] [Reference Citation Analysis]
216 Lynch HT, Nustas R, Kassim T, Snyder C, Shaw T, Diab O. The benefits of a model of interval comprehensive assessments (MICA) in hereditary cancer Syndromes: Hereditary diffuse gastric cancer (HDGC) as an example. Cancer Genetics 2019;233-234:43-7. [DOI: 10.1016/j.cancergen.2019.03.005] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
217 Azari FS, Roses RE. Management of Early Stage Gastric and Gastroesophageal Junction Malignancies. Surg Clin North Am. 2019;99:439-456. [PMID: 31047034 DOI: 10.1016/j.suc.2019.02.008] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
218 Hamilton JG, Long JM, Brandt AC, Brower J, Symecko H, Salo-Mullen EE, Christian SN, Harstad T, Couch FJ, Garber JE, Offit K, Robson ME, Domchek SM. Patients' Medical and Psychosocial Experiences After Detection of a CDH1 Variant With Multigene Panel Testing. JCO Precis Oncol 2019;3. [PMID: 31511843 DOI: 10.1200/PO.18.00300] [Cited by in Crossref: 4] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
219 Rubinstein JC, Nicolson NG, Ahuja N. Next-generation Sequencing in the Management of Gastric and Esophageal Cancers. Surg Clin North Am 2019;99:511-27. [PMID: 31047039 DOI: 10.1016/j.suc.2019.02.005] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
220 Petelin L, James PA, Trainer AH. Changing landscape of hereditary breast and ovarian cancer germline genetic testing in Australia. Intern Med J 2018;48:1269-72. [PMID: 30288903 DOI: 10.1111/imj.14058] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
221 Guindalini RSC, Cormedi MCV, Maistro S, Pasini FS, Branas PCAA, Dos Santos L, de Lima Pereira GF, de Bock GH, Saccaro DM, Katayama MLH, Faraj SF, Safatle-Ribeiro A, Ribeiro Junior U, Diz MDPE, de Gouvêa ACRC, Chammas R, Folgueira MAAK. Frequency of CDH1 germline variants and contribution of dietary habits in early age onset gastric cancer patients in Brazil. Gastric Cancer 2019;22:920-31. [PMID: 30895400 DOI: 10.1007/s10120-019-00945-9] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
222 Lutz MP, Zalcberg JR, Ducreux M, Adenis A, Allum W, Aust D, Carneiro F, Grabsch HI, Laurent-Puig P, Lordick F, Möhler M, Mönig S, Obermannova R, Piessen G, Riddell A, Röcken C, Roviello F, Schneider PM, Seewald S, Smyth E, van Cutsem E, Verheij M, Wagner AD, Otto F. The 4th St. Gallen EORTC Gastrointestinal Cancer Conference: Controversial issues in the multimodal primary treatment of gastric, junctional and oesophageal adenocarcinoma. Eur J Cancer 2019;112:1-8. [PMID: 30878666 DOI: 10.1016/j.ejca.2019.01.106] [Cited by in Crossref: 19] [Cited by in F6Publishing: 13] [Article Influence: 4.8] [Reference Citation Analysis]
223 Donida BM, Tomasello G, Ghidini M, Buffoli F, Grassi M, Liguigli W, Maglietta G, Pergola L, Ratti M, Sabadini G, Toppo L, Ungari M, Passalacqua R. Epidemiological, clinical and pathological characteristics of gastric neoplasms in the province of Cremona: the experience of the first population-based specialized gastric cancer registry in Italy. BMC Cancer 2019;19:212. [PMID: 30849945 DOI: 10.1186/s12885-019-5366-1] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
224 Skill N, Maluccio M. Contemporary paradigm for the evaluation and treatment of hereditary gastric cancer. Transl Gastroenterol Hepatol 2019;4:14. [PMID: 30976717 DOI: 10.21037/tgh.2019.01.13] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
225 Januszewicz W, Fitzgerald RC. Early detection and therapeutics. Mol Oncol. 2019;13:599-613. [PMID: 30677217 DOI: 10.1002/1878-0261.12458] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 3.3] [Reference Citation Analysis]
226 Lo W, Zhu B, Sabesan A, Wu HH, Powers A, Sorber RA, Ravichandran S, Chen I, McDuffie LA, Quadri HS, Beane JD, Calzone K, Miettinen MM, Hewitt SM, Koh C, Heller T, Wacholder S, Rudloff U. Associations of CDH1 germline variant location and cancer phenotype in families with hereditary diffuse gastric cancer (HDGC). J Med Genet. 2019;56:370-379. [PMID: 30745422 DOI: 10.1136/jmedgenet-2018-105361] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 4.5] [Reference Citation Analysis]
227 Figueiredo J, Melo S, Carneiro P, Moreira AM, Fernandes MS, Ribeiro AS, Guilford P, Paredes J, Seruca R. Clinical spectrum and pleiotropic nature of CDH1 germline mutations. J Med Genet. 2019;56:199-208. [PMID: 30661051 DOI: 10.1136/jmedgenet-2018-105807] [Cited by in Crossref: 48] [Cited by in F6Publishing: 53] [Article Influence: 12.0] [Reference Citation Analysis]
228 Drake J, Schreiber KC, Lopez R, Fasaye GA, Connolly M, Quezado M, Heller T, Hernandez JM, Davis JL. Establishing a center of excellence for hereditary diffuse gastric cancer syndrome. J Surg Oncol 2019;119:673-4. [PMID: 30618047 DOI: 10.1002/jso.25363] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
229 Carneiro F, Hruban RH. Genomic Applications in Pancreatic and Gastric Tumors. Genomic Applications in Pathology 2019. [DOI: 10.1007/978-3-319-96830-8_29] [Reference Citation Analysis]
230 Poplawski NK. Genetics of Inherited Gastrointestinal Tumors. Gastroenterology For General Surgeons 2019. [DOI: 10.1007/978-3-319-92768-8_21] [Reference Citation Analysis]
231 Knežević S, Gajović I, Đurović L. Role of general practice doctor in the treatment of Signet ring cell carcinoma. Praxis medica 2019;48:51-4. [DOI: 10.5937/pramed1902051k] [Reference Citation Analysis]
232 Guan WL, Yuan LP, Yan XL, Yang DJ, Qiu MZ. More attention should be paid to adult gastric cancer patients younger than 35 years old: extremely poor prognosis was found. J Cancer. 2019;10:472-478. [PMID: 30719142 DOI: 10.7150/jca.27517] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 3.3] [Reference Citation Analysis]
233 Funakoshi T, Miyamoto S, Kakiuchi N, Nikaido M, Setoyama T, Yokoyama A, Horimatsu T, Yamada A, Torishima M, Kosugi S, Yamada H, Sugimura H, Haga H, Sakai Y, Ogawa S, Seno H, Muto M, Chiba T. Genetic analysis of a case of Helicobacter pylori-uninfected intramucosal gastric cancer in a family with hereditary diffuse gastric cancer. Gastric Cancer. 2019;22:892-898. [PMID: 30542785 DOI: 10.1007/s10120-018-00912-w] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 3.2] [Reference Citation Analysis]
234 van der Kaaij RT, van Kessel JP, van Dieren JM, Snaebjornsson P, Balagué O, van Coevorden F, van der Kolk LE, Sikorska K, Cats A, van Sandick JW. Outcomes after prophylactic gastrectomy for hereditary diffuse gastric cancer. Br J Surg 2018;105:e176-82. [PMID: 29341148 DOI: 10.1002/bjs.10754] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 5.0] [Reference Citation Analysis]
235 Luo W, Fedda F, Lynch P, Tan D. CDH1 Gene and Hereditary Diffuse Gastric Cancer Syndrome: Molecular and Histological Alterations and Implications for Diagnosis And Treatment. Front Pharmacol. 2018;9:1421. [PMID: 30568591 DOI: 10.3389/fphar.2018.01421] [Cited by in Crossref: 42] [Cited by in F6Publishing: 45] [Article Influence: 8.4] [Reference Citation Analysis]
236 Benusiglio PR, Colas C, Guillerm E, Canard A, Delhomelle H, Warcoin M, Bellanger J, Eyries M, Zizi M, Netter J, Soubrier F, Parc Y, Mourregot A, Maran Gonzalez A, Cusin V, Denis JA, Coupier I, Svrcek M, Coulet F. Clinical implications of CTNNA1 germline mutations in asymptomatic carriers. Gastric Cancer 2019;22:899-903. [PMID: 30515673 DOI: 10.1007/s10120-018-00907-7] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 3.4] [Reference Citation Analysis]
237 Laduca H, Mcfarland R, Gutierrez S, Yussuf A, Ho N, Pepper J, Reineke P, Cain T, Blanco K, Horton C, Dolinsky JS. Quality of Clinician-Reported Cancer History When Ordering Genetic Testing. JCO Clinical Cancer Informatics 2018. [DOI: 10.1200/cci.18.00014] [Cited by in Crossref: 13] [Cited by in F6Publishing: 18] [Article Influence: 2.6] [Reference Citation Analysis]
238 Aziz M, Madan R, Bansal A. Hereditary Diffuse Gastric Cancer: More than What Meets the Endoscopic Eye. Kans J Med 2018;11:120-1. [PMID: 30937153] [Reference Citation Analysis]
239 Vangala DB, Cauchin E, Balmaña J, Wyrwicz L, van Cutsem E, Güller U, Castells A, Carneiro F, Hammel P, Ducreux M, van Laethem JL, Matysiak-Budnik T, Schmiegel W. Screening and surveillance in hereditary gastrointestinal cancers: Recommendations from the European Society of Digestive Oncology (ESDO) expert discussion at the 20th European Society for Medical Oncology (ESMO)/World Congress on Gastrointestinal Cancer, Barcelona, June 2018. Eur J Cancer 2018;104:91-103. [PMID: 30342310 DOI: 10.1016/j.ejca.2018.09.004] [Cited by in Crossref: 38] [Cited by in F6Publishing: 41] [Article Influence: 7.6] [Reference Citation Analysis]
240 Rasnic R, Brandes N, Zuk O, Linial M. Substantial Batch Effects in TCGA Exome Sequences Undermine Pan-Cancer Analysis of Germline Variants.. [DOI: 10.1101/445049] [Reference Citation Analysis]
241 Vos JR, Giepmans L, Röhl C, Geverink N, Hoogerbrugge N; ERN GENTURIS. Boosting care and knowledge about hereditary cancer: European Reference Network on Genetic Tumour Risk Syndromes. Fam Cancer 2019;18:281-4. [PMID: 30302652 DOI: 10.1007/s10689-018-0110-6] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
242 Tavera G, Morgan DR, Williams SM. Tipping the Scale Toward Gastric Disease: A Host-Pathogen Genomic Mismatch? Curr Genet Med Rep 2018;6:199-207. [PMID: 30775159 DOI: 10.1007/s40142-018-0153-x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
243 Rocha JP, Gullo I, Wen X, Devezas V, Baptista M, Oliveira C, Carneiro F. Pathological features of total gastrectomy specimens from asymptomatic hereditary diffuse gastric cancer patients and implications for clinical management. Histopathology 2018;73:878-86. [PMID: 30014492 DOI: 10.1111/his.13715] [Cited by in Crossref: 31] [Cited by in F6Publishing: 32] [Article Influence: 6.2] [Reference Citation Analysis]
244 Merriman TR, Wilcox PL. Cardio-metabolic disease genetic risk factors among Māori and Pacific Island people in Aotearoa New Zealand: current state of knowledge and future directions. Ann Hum Biol 2018;45:202-14. [PMID: 29877153 DOI: 10.1080/03014460.2018.1461929] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.4] [Reference Citation Analysis]
245 Theobald KA, Susswein LR, Marshall ML, Roberts ME, Mester JL, Speyer D, Williams RNW, Knapke SC, Solomon SR, Murphy PD, Klein RT, Hruska KS, Solomon BD. Utility of Expedited Hereditary Cancer Testing in the Surgical Management of Patients with a New Breast Cancer Diagnosis. Ann Surg Oncol 2018;25:3556-62. [PMID: 30167906 DOI: 10.1245/s10434-018-6581-8] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
246 Moslim MA, Heald B, Tu C, Burke CA, Walsh RM. Early genetic counseling and detection of CDH1 mutation in asymptomatic carriers improves survival in hereditary diffuse gastric cancer. Surgery. 2018;164:754-759. [PMID: 30145018 DOI: 10.1016/j.surg.2018.05.059] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 2.6] [Reference Citation Analysis]
247 McGee SF, AlGhareeb W, Ahmad CH, Armstrong D, Babak S, Berry S, Biagi J, Booth C, Bossé D, Champion P, Colwell B, Finn N, Goel R, Gray S, Green J, Harb M, Hyde A, Jeyakumar A, Jonker D, Kanagaratnam S, Kavan P, MacMillan A, Muinuddin A, Patil N, Porter G, Powell E, Ramjeesingh R, Raza M, Rorke S, Seal M, Servidio-Italiano F, Siddiqui J, Simms J, Smithson L, Snow S, St-Hilaire E, Stuckless T, Tate A, Tehfe M, Thirlwell M, Tsvetkova E, Valdes M, Vickers M, Virik K, Welch S, Marginean C, Asmis T. Eastern Canadian Colorectal Cancer Consensus Conference 2017. Curr Oncol 2018;25:262-74. [PMID: 30111967 DOI: 10.3747/co.25.4083] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
248 Ansari S, Gantuya B, Tuan VP, Yamaoka Y. Diffuse Gastric Cancer: A Summary of Analogous Contributing Factors for Its Molecular Pathogenicity. Int J Mol Sci 2018;19:E2424. [PMID: 30115886 DOI: 10.3390/ijms19082424] [Cited by in Crossref: 40] [Cited by in F6Publishing: 44] [Article Influence: 8.0] [Reference Citation Analysis]
249 Zaanan A, Bouché O, Benhaim L, Buecher B, Chapelle N, Dubreuil O, Fares N, Granger V, Lefort C, Gagniere J, Meilleroux J, Baumann AS, Vendrely V, Ducreux M, Michel P; Thésaurus National de Cancérologie Digestive (TNCD). Gastric cancer: French intergroup clinical practice guidelines for diagnosis, treatments and follow-up (SNFGE, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO). Dig Liver Dis 2018;50:768-79. [PMID: 29886081 DOI: 10.1016/j.dld.2018.04.025] [Cited by in Crossref: 50] [Cited by in F6Publishing: 53] [Article Influence: 10.0] [Reference Citation Analysis]
250 Krempely K, Karam R. A novel de novo CDH1 germline variant aids in the classification of carboxy-terminal E-cadherin alterations predicted to escape nonsense-mediated mRNA decay. Cold Spring Harb Mol Case Stud 2018;4:a003012. [PMID: 29798843 DOI: 10.1101/mcs.a003012] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
251 Figueiredo J, Melo S, Gamet K, Godwin T, Seixas S, Sanches JM, Guilford P, Seruca R. E-cadherin signal sequence disruption: a novel mechanism underlying hereditary cancer. Mol Cancer 2018;17:112. [PMID: 30068367 DOI: 10.1186/s12943-018-0859-0] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
252 Godwin TD, Kelly ST, Brew TP, Bougen-Zhukov NM, Single AB, Chen A, Stylianou CE, Harris LD, Currie SK, Telford BJ, Beetham HG, Evans GB, Black MA, Guilford PJ. E-cadherin-deficient cells have synthetic lethal vulnerabilities in plasma membrane organisation, dynamics and function. Gastric Cancer 2019;22:273-86. [PMID: 30066183 DOI: 10.1007/s10120-018-0859-1] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 3.4] [Reference Citation Analysis]
253 Shilova ON, Shilov ES, Lieber A, Deyev SM. Disassembling a cancer puzzle: Cell junctions and plasma membrane as targets for anticancer therapy. J Control Release 2018;286:125-36. [PMID: 30030181 DOI: 10.1016/j.jconrel.2018.07.030] [Cited by in Crossref: 9] [Cited by in F6Publishing: 13] [Article Influence: 1.8] [Reference Citation Analysis]
254 Hallowell N, Badger S, Richardson S, Caldas C, Hardwick RH, Fitzgerald RC, Lawton J. High-risk individuals' perceptions of reproductive genetic testing for CDH1 mutations. Fam Cancer 2017;16:531-5. [PMID: 28204904 DOI: 10.1007/s10689-017-9976-y] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
255 Gjyshi O, Vashi P, Seewald L, Kohan M, Abboud E, Fowler E, Suppiah R, Halabi H. Therapeutic and prophylactic gastrectomy in a family with hereditary diffuse gastric cancer secondary to a CDH1 mutation: a case series. World J Surg Oncol 2018;16:143. [PMID: 30007404 DOI: 10.1186/s12957-018-1415-5] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
256 de Castro Sant' Anna C, Junior AGF, Soares P, Tuji F, Paschoal E, Chaves LC, Burbano RR. Molecular biology as a tool for the treatment of cancer. Clin Exp Med 2018;18:457-64. [PMID: 30006681 DOI: 10.1007/s10238-018-0518-1] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 3.6] [Reference Citation Analysis]
257 Ichikawa H, Wakai T, Nagahashi M, Shimada Y, Hanyu T, Kano Y, Muneoka Y, Ishikawa T, Takizawa K, Tajima Y, Sakata J, Kobayashi T, Kemeyama H, Yabusaki H, Nakagawa S, Sato N, Kawasaki T, Homma K, Okuda S, Lyle S, Takabe K. Pathogenic germline BRCA1/2 mutations and familial predisposition to gastric cancer. JCO Precis Oncol 2018;2. [PMID: 31608315 DOI: 10.1200/PO.18.00097] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
258 van der Post RS, Carneiro F. Emerging Concepts in Gastric Neoplasia: Heritable Gastric Cancers and Polyposis Disorders. Surg Pathol Clin. 2017;10:931-945. [PMID: 29103540 DOI: 10.1016/j.path.2017.07.011] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 3.2] [Reference Citation Analysis]
259 Young EL, Thompson BA, Neklason DW, Firpo MA, Werner T, Bell R, Berger J, Fraser A, Gammon A, Koptiuch C, Kohlmann WK, Neumayer L, Goldgar DE, Mulvihill SJ, Cannon-Albright LA, Tavtigian SV. Pancreatic cancer as a sentinel for hereditary cancer predisposition. BMC Cancer 2018;18:697. [PMID: 29945567 DOI: 10.1186/s12885-018-4573-5] [Cited by in Crossref: 23] [Cited by in F6Publishing: 27] [Article Influence: 4.6] [Reference Citation Analysis]
260 Corso G, Figueiredo J, La Vecchia C, Veronesi P, Pravettoni G, Macis D, Karam R, Lo Gullo R, Provenzano E, Toesca A, Mazzocco K, Carneiro F, Seruca R, Melo S, Schmitt F, Roviello F, De Scalzi AM, Intra M, Feroce I, De Camilli E, Villardita MG, Trentin C, De Lorenzi F, Bonanni B, Galimberti V. Hereditary lobular breast cancer with an emphasis on E-cadherin genetic defect. J Med Genet 2018;55:431-41. [PMID: 29929997 DOI: 10.1136/jmedgenet-2018-105337] [Cited by in Crossref: 43] [Cited by in F6Publishing: 45] [Article Influence: 8.6] [Reference Citation Analysis]
261 Machlowska J, Maciejewski R, Sitarz R. The Pattern of Signatures in Gastric Cancer Prognosis. Int J Mol Sci. 2018;19. [PMID: 29867026 DOI: 10.3390/ijms19061658] [Cited by in Crossref: 45] [Cited by in F6Publishing: 48] [Article Influence: 9.0] [Reference Citation Analysis]
262 Polom K, Marrelli D, D'Ignazio A, Roviello F. Hereditary diffuse gastric cancer: how to look for and how to manage it. Updates Surg. 2018;70:161-166. [PMID: 29869323 DOI: 10.1007/s13304-018-0545-1] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
263 Gullo I, Devezas V, Baptista M, Garrido L, Castedo S, Morais R, Wen X, Rios E, Pinheiro J, Pinto-Ribeiro I, Ferreira RM, Preto J, Santos-Antunes J, Marques M, Campos M, Almeida F, Espinheira MDC, Amil Dias J, Figueiredo C, Oliveira C, Trindade E, Carneiro F. Phenotypic heterogeneity of hereditary diffuse gastric cancer: report of a family with early-onset disease. Gastrointest Endosc 2018;87:1566-75. [PMID: 29454568 DOI: 10.1016/j.gie.2018.02.008] [Cited by in Crossref: 30] [Cited by in F6Publishing: 28] [Article Influence: 6.0] [Reference Citation Analysis]
264 Rodrigues-antunes S, Borges BN. Alterations in mtDNA, gastric carcinogenesis and early diagnosis. Mitochondrial DNA Part A 2019;30:226-33. [DOI: 10.1080/24701394.2018.1475478] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
265 Pena-Couso L, Perea J, Melo S, Mercadillo F, Figueiredo J, Sanches JM, Sánchez-Ruiz A, Robles L, Seruca R, Urioste M. Clinical and functional characterization of the CDH1 germline variant c.1679C>G in three unrelated families with hereditary diffuse gastric cancer. Eur J Hum Genet 2018;26:1348-53. [PMID: 29769627 DOI: 10.1038/s41431-018-0173-8] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
266 Corso G, De Scalzi A, Feroce I, Veronesi P, Bonanni B, Galimberti V. Clinical criteria revision for hereditary lobular breast cancer associated with E-cadherin germline mutations. Per Med 2018;15:153-5. [PMID: 29745790 DOI: 10.2217/pme-2017-0083] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
267 Spoto CP, Gullo I, Carneiro F, Montgomery EA, Brosens LA. Hereditary gastrointestinal carcinomas and their precursors: An algorithm for genetic testing. Seminars in Diagnostic Pathology 2018;35:170-83. [DOI: 10.1053/j.semdp.2018.01.004] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 2.8] [Reference Citation Analysis]
268 Carvajal-Carmona LG. PALB2 as a familial gastric cancer gene: is the wait over? Lancet Gastroenterol Hepatol 2018;3:451-2. [PMID: 29706559 DOI: 10.1016/S2468-1253(18)30120-1] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
269 Fewings E, Larionov A, Redman J, Goldgraben MA, Scarth J, Richardson S, Brewer C, Davidson R, Ellis I, Evans DG, Halliday D, Izatt L, Marks P, McConnell V, Verbist L, Mayes R, Clark GR, Hadfield J, Chin SF, Teixeira MR, Giger OT, Hardwick R, di Pietro M, O'Donovan M, Pharoah P, Caldas C, Fitzgerald RC, Tischkowitz M. Germline pathogenic variants in PALB2 and other cancer-predisposing genes in families with hereditary diffuse gastric cancer without CDH1 mutation: a whole-exome sequencing study. Lancet Gastroenterol Hepatol 2018;3:489-98. [PMID: 29706558 DOI: 10.1016/S2468-1253(18)30079-7] [Cited by in Crossref: 54] [Cited by in F6Publishing: 60] [Article Influence: 10.8] [Reference Citation Analysis]
270 Taylor A, Brady AF, Frayling IM, Hanson H, Tischkowitz M, Turnbull C, Side L; UK Cancer Genetics Group (UK-CGG). Consensus for genes to be included on cancer panel tests offered by UK genetics services: guidelines of the UK Cancer Genetics Group. J Med Genet 2018;55:372-7. [PMID: 29661970 DOI: 10.1136/jmedgenet-2017-105188] [Cited by in Crossref: 58] [Cited by in F6Publishing: 61] [Article Influence: 11.6] [Reference Citation Analysis]
271 Šašková B, Daum O, Dubová M, Pivovarčíková K, Švajdler M. Precursors of gastric adenocarcinoma. Onkologie 2018;12:56-62. [DOI: 10.36290/xon.2018.012] [Reference Citation Analysis]
272 Corso G, Macis D, Veronesi P, Bonanni B, Galimberti V. The Italian Ministry of Health promotes more than 300 research projects to improve cancer prevention, treatment, and prognosis. Eur J Cancer Prev 2018;27:287-8. [PMID: 29570106 DOI: 10.1097/CEJ.0000000000000443] [Reference Citation Analysis]
273 Bruner HC, Derksen PWB. Loss of E-Cadherin-Dependent Cell-Cell Adhesion and the Development and Progression of Cancer. Cold Spring Harb Perspect Biol 2018;10:a029330. [PMID: 28507022 DOI: 10.1101/cshperspect.a029330] [Cited by in Crossref: 78] [Cited by in F6Publishing: 94] [Article Influence: 15.6] [Reference Citation Analysis]
274 Li D, Lo W, Rudloff U. Merging perspectives: genotype-directed molecular therapy for hereditary diffuse gastric cancer (HDGC) and E-cadherin-EGFR crosstalk. Clin Transl Med 2018;7:7. [PMID: 29468433 DOI: 10.1186/s40169-018-0184-7] [Cited by in Crossref: 17] [Cited by in F6Publishing: 20] [Article Influence: 3.4] [Reference Citation Analysis]
275 Yadav S, Reeves A, Campian S, Paine A, Zakalik D. Outcomes of retesting BRCA negative patients using multigene panels. Fam Cancer 2017;16:319-28. [PMID: 27878467 DOI: 10.1007/s10689-016-9956-7] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
276 Corso G, Bonanni B, Veronesi P, Galimberti V. Mutual exclusion of CDH1 and BRCA germline mutations in the pathway of hereditary breast cancer. Arch Gynecol Obstet 2018;297:1067-8. [PMID: 29397440 DOI: 10.1007/s00404-018-4705-9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
277 Mi EZ, Mi EZ, di Pietro M, O'Donovan M, Hardwick RH, Richardson S, Ziauddeen H, Fletcher PC, Caldas C, Tischkowitz M, Ragunath K, Fitzgerald RC. Comparative study of endoscopic surveillance in hereditary diffuse gastric cancer according to CDH1 mutation status. Gastrointest Endosc 2018;87:408-18. [PMID: 28688938 DOI: 10.1016/j.gie.2017.06.028] [Cited by in Crossref: 62] [Cited by in F6Publishing: 58] [Article Influence: 12.4] [Reference Citation Analysis]
278 de Almeida Artifon EL, Marinho FRT. Endoscopic screening for hereditary diffuse gastric cancer: one size does not fit all. Gastrointest Endosc 2018;87:405-7. [PMID: 29406927 DOI: 10.1016/j.gie.2017.05.042] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
279 van der Post RS, van Dieren J, Grelack A, Hoogerbrugge N, van der Kolk LE, Snaebjornsson P, Lansdorp-Vogelaar I, van Krieken JH, Bisseling TM, Cats A. Outcomes of screening gastroscopy in first-degree relatives of patients fulfilling hereditary diffuse gastric cancer criteria. Gastrointest Endosc 2018;87:397-404.e2. [PMID: 28455161 DOI: 10.1016/j.gie.2017.04.016] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 3.4] [Reference Citation Analysis]
280 Altman AM, Hui JYC, Tuttle TM. Quality-of-life implications of risk-reducing cancer surgery. British Journal of Surgery 2018;105:e121-30. [DOI: 10.1002/bjs.10725] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.4] [Reference Citation Analysis]
281 Zylberberg HM, Sultan K, Rubin S. Hereditary diffuse gastric cancer: One family’s story. World J Clin Cases 2018; 6(1): 1-5 [PMID: 29376063 DOI: 10.12998/wjcc.v6.i1.1] [Cited by in CrossRef: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
282 Weren RDA, van der Post RS, Vogelaar IP, van Krieken JH, Spruijt L, Lubinski J, Jakubowska A, Teodorczyk U, Aalfs CM, van Hest LP, Oliveira C, Kamping EJ, Schackert HK, Ranzani GN, Gómez García EB, Hes FJ, Holinski-Feder E, Genuardi M, Ausems MGEM, Sijmons RH, Wagner A, van der Kolk LE, Cats A, Bjørnevoll I, Hoogerbrugge N, Ligtenberg MJL. Role of germline aberrations affecting CTNNA1, MAP3K6 and MYD88 in gastric cancer susceptibility. J Med Genet 2018;55:669-74. [PMID: 29330337 DOI: 10.1136/jmedgenet-2017-104962] [Cited by in Crossref: 28] [Cited by in F6Publishing: 28] [Article Influence: 5.6] [Reference Citation Analysis]
283 Lee HE, Smyrk TC, Zhang L. Histologic and immunohistochemical differences between hereditary and sporadic diffuse gastric carcinoma. Hum Pathol 2018;74:64-72. [PMID: 29307626 DOI: 10.1016/j.humpath.2017.12.023] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 3.4] [Reference Citation Analysis]
284 Allum W, Lordick F, Alsina M, Andritsch E, Ba-Ssalamah A, Beishon M, Braga M, Caballero C, Carneiro F, Cassinello F, Dekker JW, Delgado-Bolton R, Haustermans K, Henning G, Hutter B, Lövey J, Netíková IŠ, Obermannová R, Oberst S, Rostoft S, Saarto T, Seufferlein T, Sheth S, Wynter-Blyth V, Costa A, Naredi P. ECCO essential requirements for quality cancer care: Oesophageal and gastric cancer. Crit Rev Oncol Hematol 2018;122:179-93. [PMID: 29458786 DOI: 10.1016/j.critrevonc.2017.12.019] [Cited by in Crossref: 27] [Cited by in F6Publishing: 26] [Article Influence: 5.4] [Reference Citation Analysis]
285 Verheij M. Radiation Therapy in Gastric Cancer. Radiation Oncology 2018. [DOI: 10.1007/978-3-319-52619-5_42-1] [Reference Citation Analysis]
286 Ribeiro U, Perrotta FS. The Role of Surgery. Diffuse Gastric Cancer 2018. [DOI: 10.1007/978-3-319-95234-5_6] [Reference Citation Analysis]
287 Zhang H, Feng M, Feng Y, Bu Z, Li Z, Jia S, Ji J. Germline mutations in hereditary diffuse gastric cancer. Chin J Cancer Res 2018;30:122-30. [PMID: 29545726 DOI: 10.21147/j.issn.1000-9604.2018.01.13] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
288 Barra WF, Demachki S, Ishak G, de Assumpção PP. Epidemiology. Diffuse Gastric Cancer 2018. [DOI: 10.1007/978-3-319-95234-5_2] [Reference Citation Analysis]
289 Gullo I, Carneiro F. Gastric Cancer: Pathology and Genetics ☆. Reference Module in Biomedical Sciences 2018. [DOI: 10.1016/b978-0-12-801238-3.65076-6] [Reference Citation Analysis]
290 Bakulin IG, Pirogov SS, Bakulina NV, Stadnik EA, Golubev NN. Prophylaxis and early diagnosis of stomach cancer. Dok gastroenterol 2018;7:44. [DOI: 10.17116/dokgastro201872244] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
291 Katona BW, Lynch JP. Mechanisms of Gastrointestinal Malignancies. Physiology of the Gastrointestinal Tract 2018. [DOI: 10.1016/b978-0-12-809954-4.00066-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
292 de Gouvea ACRC, Silva ACB, Victor CR, Mendoza EZ, Nardo M, Guindalini RSC. Genetic Predisposition and Hereditary Syndromes. Diffuse Gastric Cancer 2018. [DOI: 10.1007/978-3-319-95234-5_5] [Reference Citation Analysis]
293 Stomach: Diagnosis and Margins. Diagnostic Pathology: Intraoperative Consultation 2018. [DOI: 10.1016/b978-0-323-57019-0.50073-x] [Reference Citation Analysis]
294 Glogowski E, Schrader KA, Stratton KL, Offit K. Counseling and Testing for Inherited Predisposition to Cancer. The American Cancer Society's Principles of Oncology 2017. [DOI: 10.1002/9781119468868.ch5] [Reference Citation Analysis]
295 Marotti JD, Schnitt SJ. Genotype-Phenotype Correlations in Breast Cancer. Surg Pathol Clin 2018;11:199-211. [PMID: 29413657 DOI: 10.1016/j.path.2017.09.008] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
296 Melo S, Figueiredo J, Fernandes MS, Gonçalves M, Morais-de-Sá E, Sanches JM, Seruca R. Predicting the Functional Impact of CDH1 Missense Mutations in Hereditary Diffuse Gastric Cancer. Int J Mol Sci 2017;18:E2687. [PMID: 29231860 DOI: 10.3390/ijms18122687] [Cited by in Crossref: 30] [Cited by in F6Publishing: 33] [Article Influence: 5.0] [Reference Citation Analysis]
297 Wen HY, Brogi E. Lobular Carcinoma In Situ. Surg Pathol Clin 2018;11:123-45. [PMID: 29413653 DOI: 10.1016/j.path.2017.09.009] [Cited by in Crossref: 36] [Cited by in F6Publishing: 27] [Article Influence: 6.0] [Reference Citation Analysis]
298 Strong VE, Gholami S, Shah MA, Tang LH, Janjigian YY, Schattner M, Selby LV, Yoon SS, Salo-Mullen E, Stadler ZK, Kelsen D, Brennan MF, Coit DG. Total Gastrectomy for Hereditary Diffuse Gastric Cancer at a Single Center: Postsurgical Outcomes in 41 Patients. Ann Surg 2017;266:1006-12. [PMID: 27759617 DOI: 10.1097/SLA.0000000000002030] [Cited by in Crossref: 37] [Cited by in F6Publishing: 41] [Article Influence: 6.2] [Reference Citation Analysis]
299 Wong SHM, Fang CM, Chuah LH, Leong CO, Ngai SC. E-cadherin: Its dysregulation in carcinogenesis and clinical implications. Crit Rev OncolHematol. 2018;121:11-22. [PMID: 29279096 DOI: 10.1016/j.critrevonc.2017.11.010] [Cited by in Crossref: 177] [Cited by in F6Publishing: 203] [Article Influence: 29.5] [Reference Citation Analysis]
300 Powers B, Pal T, Laronga C. Considerations in Testing for Inherited Breast Cancer Predisposition in the Era of Personalized Medicine. Surg Oncol Clin N Am 2018;27:1-22. [PMID: 29132555 DOI: 10.1016/j.soc.2017.08.003] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
301 Caggiari L, Miolo G, Canzonieri V, De Zorzi M, Alessandrini L, Corona G, Cannizzaro R, Santeufemia DA, Cossu A, Buonadonna A, De Re V. A new mutation of the CDH1 gene in a patient with an aggressive signet-ring cell carcinoma of the stomach. Cancer Biol Ther 2018;19:254-9. [PMID: 29131691 DOI: 10.1080/15384047.2017.1394540] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
302 Lowstuter K, Espenschied CR, Sturgeon D, Ricker C, Karam R, Laduca H, Culver JO, Dolinsky JS, Chao E, Sturgeon J, Speare V, Ma Y, Kingham K, Melas M, Idos GE, Mcdonnell KJ, Gruber SB. Unexpected CDH1 Mutations Identified on Multigene Panels Pose Clinical Management Challenges. JCO Precision Oncology 2017. [DOI: 10.1200/po.16.00021] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 2.2] [Reference Citation Analysis]
303 Ford JM. Totally Unexpected: Nonsyndromic CDH1 Mutations and Hereditary Diffuse Gastric Cancer Syndrome. JCO Precision Oncology 2017. [DOI: 10.1200/po.17.00006] [Reference Citation Analysis]
304 Afghahi A, Kurian AW. The Changing Landscape of Genetic Testing for Inherited Breast Cancer Predisposition. Curr Treat Options Oncol 2017;18:27. [PMID: 28439798 DOI: 10.1007/s11864-017-0468-y] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 3.5] [Reference Citation Analysis]
305 Leachman SA, Lucero OM, Sampson JE, Cassidy P, Bruno W, Queirolo P, Ghiorzo P. Identification, genetic testing, and management of hereditary melanoma. Cancer Metastasis Rev 2017;36:77-90. [PMID: 28283772 DOI: 10.1007/s10555-017-9661-5] [Cited by in Crossref: 67] [Cited by in F6Publishing: 73] [Article Influence: 11.2] [Reference Citation Analysis]
306 Stuebs F, Heidemann S, Caliebe A, Mundhenke C, Arnold N. CDH1 mutation screen in a BRCA1/2-negative familial breast-/ovarian cancer cohort. Arch Gynecol Obstet 2018;297:147-52. [PMID: 28993866 DOI: 10.1007/s00404-017-4551-1] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.7] [Reference Citation Analysis]
307 Young EL, Thompson BA, Neklason DW, Snow AK, Firpo MA, Werner T, Bell R, Sutherland NR, Smith KR, Berger J, Fraser A, Gammon A, Koptiuch C, Kohlmann WK, Neumayer L, Goldgar DE, Mulvihill SJ, Cannon-albright LA, Tavtigian SV. Universal Panel Testing of Pancreatic Cancer Cases for Cancer Predisposition.. [DOI: 10.1101/195537] [Reference Citation Analysis]
308 Hallowell N, Badger S, Richardson S, Caldas C, Hardwick RH, Fitzgerald RC, Lawton J. An investigation of the factors effecting high-risk individuals' decision-making about prophylactic total gastrectomy and surveillance for hereditary diffuse gastric cancer (HDGC). Fam Cancer. 2016;15:665-676. [PMID: 27256430 DOI: 10.1007/s10689-016-9910-8] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 3.7] [Reference Citation Analysis]
309 Figueiredo J, Ribeiro A, Mestre T, Esménio S, Fonseca M, Paredes J, Seruca R, Sanches J. Capturing quantitative features of protein expression fromin situfluorescence microscopic images of cancer cell populations. Fluorescence Imaging and Biological Quantification 2017. [DOI: 10.1201/9781315121017-18] [Reference Citation Analysis]
310 Tabatabaiefar MA, Moridnia A. Gastrointestinal Cancers. In: Mehdipour P, editor. Cancer Genetics and Psychotherapy. Cham: Springer International Publishing; 2017. pp. 589-625. [DOI: 10.1007/978-3-319-64550-6_12] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
311 Vogelaar IP, van der Post RS, van Krieken JHJ, Spruijt L, van Zelst-Stams WA, Kets CM, Lubinski J, Jakubowska A, Teodorczyk U, Aalfs CM, van Hest LP, Pinheiro H, Oliveira C, Jhangiani SN, Muzny DM, Gibbs RA, Lupski JR, de Ligt J, Vissers LELM, Hoischen A, Gilissen C, van de Vorst M, Goeman JJ, Schackert HK, Ranzani GN, Molinaro V, Gómez García EB, Hes FJ, Holinski-Feder E, Genuardi M, Ausems MGEM, Sijmons RH, Wagner A, van der Kolk LE, Bjørnevoll I, Høberg-Vetti H, van Kessel AG, Kuiper RP, Ligtenberg MJL, Hoogerbrugge N. Unraveling genetic predisposition to familial or early onset gastric cancer using germline whole-exome sequencing. Eur J Hum Genet 2017;25:1246-52. [PMID: 28875981 DOI: 10.1038/ejhg.2017.138] [Cited by in Crossref: 27] [Cited by in F6Publishing: 28] [Article Influence: 4.5] [Reference Citation Analysis]
312 Bornschein J, Schlosser S. Pathogenese und Prävention des Magenkarzinoms. Gastroenterologe 2017;12:365-375. [DOI: 10.1007/s11377-017-0189-6] [Reference Citation Analysis]
313 Mahar AL, Kagedan DJ, Hallet J, Coburn NG. Re: Secondary gastric cancer following a breast cancer diagnosis; beware of metastatic breast cancer. Breast 2017;35:221. [PMID: 28774554 DOI: 10.1016/j.breast.2017.07.011] [Reference Citation Analysis]
314 Ghersin I, Katz LH. Gastric cancer in a teenager: a case report. Int J Adolesc Med Health 2017;31:/j/ijamh. [PMID: 28779571 DOI: 10.1515/ijamh-2017-0078] [Reference Citation Analysis]
315 Quadri HS, Smaglo BG, Morales SJ, Phillips AC, Martin AD, Chalhoub WM, Haddad NG, Unger KR, Levy AD, Al-Refaie WB. Gastric Adenocarcinoma: A Multimodal Approach.Front Surg. 2017;4:42. [PMID: 28824918 DOI: 10.3389/fsurg.2017.00042] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
316 Miyamoto T, Tanikawa C, Yodsurang V, Zhang YZ, Imoto S, Yamaguchi R, Miyano S, Nakagawa H, Matsuda K. Identification of a p53-repressed gene module in breast cancer cells. Oncotarget 2017;8:55821-36. [PMID: 28915555 DOI: 10.18632/oncotarget.19608] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
317 Betés M, Alonso-Sierra M, Valentí V, Patiño A. A multidisciplinary approach allows identification of a new pathogenic CDH1 germline missense mutation in a hereditary diffuse gastric cancer family. Dig Liver Dis 2017;49:825-6. [PMID: 28487081 DOI: 10.1016/j.dld.2017.04.006] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
318 Figueiredo C, Camargo MC, Leite M, Fuentes-Pananá EM, Rabkin CS, Machado JC. Pathogenesis of Gastric Cancer: Genetics and Molecular Classification. Curr Top Microbiol Immunol 2017;400:277-304. [PMID: 28124158 DOI: 10.1007/978-3-319-50520-6_12] [Cited by in Crossref: 27] [Cited by in F6Publishing: 34] [Article Influence: 4.5] [Reference Citation Analysis]
319 Macklin S, Gass J, Mitri G, Atwal PS, Hines S. The role of screening MRI in the era of next generation sequencing and moderate-risk genetic mutations. Fam Cancer 2018;17:167-73. [PMID: 28643015 DOI: 10.1007/s10689-017-0007-9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
320 Barone D, Cito L, Tommonaro G, Abate AA, Penon D, De Prisco R, Penon A, Forte IM, Benedetti E, Cimini A, Indovina P, Nicolaus B, Pentimalli F, Giordano A. Antitumoral potential, antioxidant activity and carotenoid content of two Southern Italy tomato cultivars extracts: San Marzano and Corbarino. J Cell Physiol 2018;233:1266-77. [DOI: 10.1002/jcp.25995] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 3.8] [Reference Citation Analysis]
321 Pollheimer MJ, Langner C. [Pathology of the R1 classification in visceral cancer surgery]. Chirurg 2017;88:731-9. [PMID: 28593347 DOI: 10.1007/s00104-017-0448-6] [Reference Citation Analysis]
322 Dörner J, Ambe PC, Möslein G. Chirurgische Prävention hereditärer gastrointestinaler Tumordispositionen. Onkologe 2017;23:446-452. [DOI: 10.1007/s00761-017-0222-x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
323 Mahar AL, Kagedan DJ, Hallet J, Coburn NG. Secondary gastric cancer malignancies following a breast cancer diagnosis: A population-based analysis. The Breast 2017;33:34-7. [DOI: 10.1016/j.breast.2017.02.012] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
324 Peterson LE, Kovyrshina T. Progression inference for somatic mutations in cancer. Heliyon 2017;3:e00277. [PMID: 28492066 DOI: 10.1016/j.heliyon.2017.e00277] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
325 Langner C. Hereditäres Magen- und Pankreaskarzinom. Pathologe 2017;38:164-9. [DOI: 10.1007/s00292-017-0297-6] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
326 Barke LD, Freivogel ME. Breast Cancer Risk Assessment Models and High-Risk Screening. Radiologic Clinics of North America 2017;55:457-74. [DOI: 10.1016/j.rcl.2016.12.013] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 2.7] [Reference Citation Analysis]
327 Strand MS, Lockhart AC, Fields RC. Genetics of Gastric Cancer. Surg Clin North Am. 2017;97:345-370. [PMID: 28325191 DOI: 10.1016/j.suc.2016.11.009] [Cited by in Crossref: 24] [Cited by in F6Publishing: 30] [Article Influence: 4.0] [Reference Citation Analysis]
328 Benusiglio PR. CDH1 germline mutations: different syndromes, same management? Genet Med 2017;19:965-6. [PMID: 28425982 DOI: 10.1038/gim.2017.24] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
329 Machado RA, de Freitas EM, de Aquino SN, Martelli DR, Swerts MS, Reis SR, Persuhn DC, Moreira HS, Dias VO, Coletta RD, Martelli-Júnior H. Clinical relevance of breast and gastric cancer-associated polymorphisms as potential susceptibility markers for oral clefts in the Brazilian population. BMC Med Genet 2017;18:39. [PMID: 28376813 DOI: 10.1186/s12881-017-0390-y] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
330 Sahasrabudhe R, Lott P, Bohorquez M, Toal T, Estrada AP, Suarez JJ, Brea-Fernández A, Cameselle-Teijeiro J, Pinto C, Ramos I, Mantilla A, Prieto R, Corvalan A, Norero E, Alvarez C, Tapia T, Carvallo P, Gonzalez LM, Cock-Rada A, Solano A, Neffa F, Della Valle A, Yau C, Soares G, Borowsky A, Hu N, He LJ, Han XY, Taylor PR, Goldstein AM, Torres J, Echeverry M, Ruiz-Ponte C, Teixeira MR, Carvajal-Carmona LG; Latin American Gastric Cancer Genetics Collaborative Group. Germline Mutations in PALB2, BRCA1, and RAD51C, Which Regulate DNA Recombination Repair, in Patients With Gastric Cancer. Gastroenterology 2017;152:983-986.e6. [PMID: 28024868 DOI: 10.1053/j.gastro.2016.12.010] [Cited by in Crossref: 67] [Cited by in F6Publishing: 73] [Article Influence: 11.2] [Reference Citation Analysis]
331 Chang KK, Patel MS, Yoon SS. Linear-Stapled Side-to-Side Esophagojejunostomy with Hand-Sewn Closure of the Common Enterotomy After Prophylactic and Therapeutic Total Gastrectomy. J Gastrointest Surg 2017;21:712-22. [PMID: 27882512 DOI: 10.1007/s11605-016-3326-5] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
332 Roberts G, Hardwick R, Fitzgerald RC. Decision making, quality of life and prophylactic gastrectomy in carriers of pathogenic CDH1 mutations. Transl Gastroenterol Hepatol 2017;2:21. [PMID: 28447056 DOI: 10.21037/tgh.2017.03.12] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
333 Ghoumid J, Stichelbout M, Jourdain AS, Frenois F, Lejeune-Dumoulin S, Alex-Cordier MP, Lebrun M, Guerreschi P, Duquennoy-Martinot V, Vinchon M, Ferri J, Jung M, Vicaire S, Vanlerberghe C, Escande F, Petit F, Manouvrier-Hanu S. Blepharocheilodontic syndrome is a CDH1 pathway-related disorder due to mutations in CDH1 and CTNND1. Genet Med 2017;19:1013-21. [PMID: 28301459 DOI: 10.1038/gim.2017.11] [Cited by in Crossref: 30] [Cited by in F6Publishing: 33] [Article Influence: 5.0] [Reference Citation Analysis]
334 Boland CR, Yurgelun MB. Historical Perspective on Familial Gastric Cancer. Cell Mol Gastroenterol Hepatol 2017;3:192-200. [PMID: 28275686 DOI: 10.1016/j.jcmgh.2016.12.003] [Cited by in Crossref: 19] [Cited by in F6Publishing: 22] [Article Influence: 3.2] [Reference Citation Analysis]
335 Röcken C. Molecular classification of gastric cancer. Expert Rev Mol Diagn 2017;17:293-301. [PMID: 28118758 DOI: 10.1080/14737159.2017.1286985] [Cited by in Crossref: 47] [Cited by in F6Publishing: 46] [Article Influence: 7.8] [Reference Citation Analysis]
336 Kamps R, Brandão RD, Bosch BJ, Paulussen AD, Xanthoulea S, Blok MJ, Romano A. Next-Generation Sequencing in Oncology: Genetic Diagnosis, Risk Prediction and Cancer Classification. Int J Mol Sci 2017;18:E308. [PMID: 28146134 DOI: 10.3390/ijms18020308] [Cited by in Crossref: 251] [Cited by in F6Publishing: 264] [Article Influence: 41.8] [Reference Citation Analysis]
337 Röcken C. [Gastric tumors and tumor precursors]. Pathologe 2017;38:75-86. [PMID: 28084526 DOI: 10.1007/s00292-016-0259-4] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
338 Katona BW, Rustgi AK. Gastric Cancer Genomics: Advances and Future Directions. Cell Mol Gastroenterol Hepatol 2017;3:211-7. [PMID: 28275688 DOI: 10.1016/j.jcmgh.2017.01.003] [Cited by in Crossref: 47] [Cited by in F6Publishing: 50] [Article Influence: 7.8] [Reference Citation Analysis]
339 Fujisaki J. III. Gastrointestinal Diseases in the Era without <i>Helicobacter pylori</i> Infection: Characteristic Findings of <i>Helicobacter pylori</i> Uninfected Gastric Cancers. J Jpn Soc Intern Med 2017;106:23-32. [DOI: 10.2169/naika.106.23] [Reference Citation Analysis]
340 Sakellis CG, Jacene HA, Van den Abbeele AD. Diagnostic Applications of Nuclear Medicine: Gastric Cancers. Nuclear Oncology 2017. [DOI: 10.1007/978-3-319-26236-9_14] [Reference Citation Analysis]
341 Schumacher J. Familiäre Magenkarzinome. Moderne Chirurgie des Magen- und Kardiakarzinoms 2017. [DOI: 10.1007/978-3-662-53188-4_3] [Reference Citation Analysis]
342 de Gouvea ACRC, Garber JE. Breast Cancer Genetics. Breast Cancer 2017. [DOI: 10.1007/978-3-319-48848-6_8] [Reference Citation Analysis]
343 Röcken C. Histopathologie des Magen- und Kardiakarzinoms. Moderne Chirurgie des Magen- und Kardiakarzinoms 2017. [DOI: 10.1007/978-3-662-53188-4_2] [Reference Citation Analysis]
344 van der Post CRS, Carneiro F. E-Cadherin, Hereditary Diffuse Gastric Cancer. Encyclopedia of Pathology 2017. [DOI: 10.1007/978-3-319-40560-5_1586] [Reference Citation Analysis]
345 Corso G, Intra M, Trentin C, Veronesi P, Galimberti V. CDH1 germline mutations and hereditary lobular breast cancer. Fam Cancer. 2016;15:215-219. [PMID: 26759166 DOI: 10.1007/s10689-016-9869-5] [Cited by in Crossref: 72] [Cited by in F6Publishing: 76] [Article Influence: 10.3] [Reference Citation Analysis]
346 Brandão C, Dinis-Ribeiro M. Early diagnosis of hereditary diffuse gastric cancer: (not only) an endoscopic challenge! Endosc Int Open 2016;4:E1311-2. [PMID: 27995194 DOI: 10.1055/s-0042-121003] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
347 Shepard B, Yoder L, Holmes C. Prophylactic Total Gastrectomy for Hereditary Diffuse Gastric Cancer. ACG Case Rep J. 2016;3:e179. [PMID: 28008412 DOI: 10.14309/crj.2016.152] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
348 Moreira L, Castells A. Surveillance of patients with hereditary gastrointestinal cancer syndromes. Best Pract Res Clin Gastroenterol 2016;30:923-35. [PMID: 27938787 DOI: 10.1016/j.bpg.2016.10.004] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
349 Muir J, Aronson M, Esplen MJ, Pollett A, Swallow CJ. Prophylactic Total Gastrectomy: a Prospective Cohort Study of Long-Term Impact on Quality of Life. J Gastrointest Surg 2016;20:1950-8. [PMID: 27752808 DOI: 10.1007/s11605-016-3287-8] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 3.4] [Reference Citation Analysis]
350 Huang B, Ni M, Chen C, Feng Y, Cai S. Younger Age Is Associated with Poorer Survival in Patients with Signet-Ring Cell Carcinoma of the Colon without Distant Metastasis. Gastroenterol Res Pract 2016;2016:2913493. [PMID: 27994618 DOI: 10.1155/2016/2913493] [Cited by in Crossref: 5] [Cited by in F6Publishing: 10] [Article Influence: 0.7] [Reference Citation Analysis]
351 Hallowell N, Lawton J, Badger S, Richardson S, Hardwick RH, Caldas C, Fitzgerald RC. The Psychosocial Impact of Undergoing Prophylactic Total Gastrectomy (PTG) to Manage the Risk of Hereditary Diffuse Gastric Cancer (HDGC). J Genet Couns. 2017;26:752-762. [PMID: 27837291 DOI: 10.1007/s10897-016-0045-8] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 2.9] [Reference Citation Analysis]
352 Repak R, Kohoutova D, Podhola M, Rejchrt S, Minarik M, Benesova L, Lesko M, Bures J. The first European family with gastric adenocarcinoma and proximal polyposis of the stomach: case report and review of the literature. Gastrointest Endosc 2016;84:718-25. [PMID: 27343414 DOI: 10.1016/j.gie.2016.06.023] [Cited by in Crossref: 35] [Cited by in F6Publishing: 34] [Article Influence: 5.0] [Reference Citation Analysis]
353 Pantelis D, Hüneburg R, Adam R, Holzapfel S, Gevensleben H, Nattermann J, Strassburg CP, Aretz S, Kalff JC. Prophylactic total gastrectomy in the management of hereditary tumor syndromes. Int J Colorectal Dis 2016;31:1825-33. [PMID: 27682646 DOI: 10.1007/s00384-016-2656-9] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
354 Petrovchich I, Ford JM. Genetic predisposition to gastric cancer. Semin Oncol. 2016;43:554-559. [PMID: 27899187 DOI: 10.1053/j.seminoncol.2016.08.006] [Cited by in Crossref: 48] [Cited by in F6Publishing: 53] [Article Influence: 6.9] [Reference Citation Analysis]
355 Carvalho S, Reis CA, Pinho SS. Cadherins Glycans in Cancer: Sweet Players in a Bitter Process. Trends Cancer 2016;2:519-31. [PMID: 28741480 DOI: 10.1016/j.trecan.2016.08.003] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 3.6] [Reference Citation Analysis]
356 Smyth EC, Verheij M, Allum W, Cunningham D, Cervantes A, Arnold D;  ESMO Guidelines Committee. Gastric cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2016;27:v38-v49. [PMID: 27664260 DOI: 10.1093/annonc/mdw350] [Cited by in Crossref: 869] [Cited by in F6Publishing: 947] [Article Influence: 124.1] [Reference Citation Analysis]
357 Stoffel EM. Heritable Gastrointestinal Cancer Syndromes. Gastroenterol Clin North Am 2016;45:509-27. [PMID: 27546846 DOI: 10.1016/j.gtc.2016.04.008] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.9] [Reference Citation Analysis]
358 Cohen SA, Nixon DM. A collaborative approach to cancer risk assessment services using genetic counselor extenders in a multi-system community hospital. Breast Cancer Res Treat 2016;159:527-34. [PMID: 27581128 DOI: 10.1007/s10549-016-3964-z] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 2.1] [Reference Citation Analysis]
359 Hüneburg R, Marwitz T, van Heteren P, Weismüller TJ, Trebicka J, Adam R, Aretz S, Perez Bouza A, Pantelis D, Kalff JC, Nattermann J, Strassburg CP. Chromoendoscopy in combination with random biopsies does not improve detection of gastric cancer foci in CDH1 mutation positive patients. Endosc Int Open 2016;4:E1305-10. [PMID: 27995193 DOI: 10.1055/s-0042-112582] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 2.7] [Reference Citation Analysis]
360 Hugen S, Thomas RE, German AJ, Burgener IA, Mandigers PJJ. Gastric carcinoma in canines and humans, a review. Vet Comp Oncol 2017;15:692-705. [PMID: 27549077 DOI: 10.1111/vco.12249] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 2.7] [Reference Citation Analysis]
361 Ahmad SA, Xia BT, Bailey CE, Abbott DE, Helmink BA, Daly MC, Thota R, Schlegal C, Winer LK, Ahmad SA, Al Humaidi AH, Parikh AA. An update on gastric cancer. Curr Probl Surg 2016;53:449-90. [PMID: 27671911 DOI: 10.1067/j.cpsurg.2016.08.001] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 3.6] [Reference Citation Analysis]
362 Rogers M. Cate’s Story: Hereditary Diffuse Gastric Cancer. CJON 2016;20:443-445. [DOI: 10.1188/16.cjon.443-445] [Reference Citation Analysis]
363 Leoz ML, Sánchez A, Carballal S, Ruano L, Ocaña T, Pellisé M, Castells A, Balaguer F, Moreira L. Hereditary gastric and pancreatic cancer predisposition syndromes. Gastroenterología y Hepatología (English Edition) 2016;39:481-93. [DOI: 10.1016/j.gastre.2016.06.010] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
364 Wenger TL, Earl D, Chow P, Sanchez-lara PA. Role of Pediatric Geneticists in Craniofacial Teams: The Identification of Craniofacial Conditions with Cancer Predisposition. The Journal of Pediatrics 2016;175:216-223.e1. [DOI: 10.1016/j.jpeds.2016.04.061] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
365 Corvalán AH, Maturana MJ. [Infections and epigenetic changes in cancer]. Rev Chil Pediatr 2016;87:245-9. [PMID: 27474231 DOI: 10.1016/j.rchipe.2016.06.008] [Reference Citation Analysis]
366 López M, Cervera-Acedo C, Santibáñez P, Salazar R, Sola JJ, Domínguez-Garrido E. A novel mutation in the CDH1 gene in a Spanish family with hereditary diffuse gastric cancer. Springerplus 2016;5:1181. [PMID: 27512640 DOI: 10.1186/s40064-016-2852-7] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
367 Fredericks C, Broucek J, Kumar V, Luu M. Laparoscopic Gastrectomy for CDH-1 Mutation. The American Surgeon 2016;82:169-170. [DOI: 10.1177/000313481608200716] [Reference Citation Analysis]
368 Suárez-Arriaga MC, Ribas-Aparicio RM, Ruiz-Tachiquín ME. MicroRNAs in hereditary diffuse gastric cancer. Biomed Rep 2016;5:151-4. [PMID: 27446532 DOI: 10.3892/br.2016.706] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
369 Mestre T, Figueiredo J, Ribeiro AS, Paredes J, Seruca R, Sanches JM. Quantification of topological features in cell meshes to explore E-cadherin dysfunction. Sci Rep 2016;6:25101. [PMID: 27151223 DOI: 10.1038/srep25101] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 2.0] [Reference Citation Analysis]
370 Rugge M, Genta RM, Graham DY, Di Mario F, Vaz Coelho LG, Kim N, Malfertheiner P, Sugano K, Tsukanov V, Correa P. Chronicles of a cancer foretold: 35 years of gastric cancer risk assessment. Gut 2016;65:721-5. [PMID: 26927528 DOI: 10.1136/gutjnl-2015-310846] [Cited by in Crossref: 47] [Cited by in F6Publishing: 38] [Article Influence: 6.7] [Reference Citation Analysis]
371 Kurian AW, Antoniou AC, Domchek SM. Refining Breast Cancer Risk Stratification: Additional Genes, Additional Information. American Society of Clinical Oncology Educational Book 2016. [DOI: 10.1200/edbk_158817] [Cited by in Crossref: 7] [Cited by in F6Publishing: 17] [Article Influence: 1.0] [Reference Citation Analysis]
372 Monahan KJ, Hopkins L. Diagnosis and Management of Hereditary Gastric Cancer. In: Pichert G, Jacobs C, editors. Rare Hereditary Cancers. Cham: Springer International Publishing; 2016. pp. 45-60. [DOI: 10.1007/978-3-319-29998-3_4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
373 Gonzalez RS, Riddle ND. Syndrome-Associated Tumors by Organ System. J Pediatr Genet 2016;5:105-15. [PMID: 27617151 DOI: 10.1055/s-0036-1580597] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
374 Lordick F, Janjigian YY. Clinical impact of tumour biology in the management of gastroesophageal cancer. Nat Rev Clin Oncol. 2016;13:348-360. [PMID: 26925958 DOI: 10.1038/nrclinonc.2016.15] [Cited by in Crossref: 93] [Cited by in F6Publishing: 102] [Article Influence: 13.3] [Reference Citation Analysis]
375 Leoz ML, Sánchez A, Carballal S, Ruano L, Ocaña T, Pellisé M, Castells A, Balaguer F, Moreira L. [Hereditary gastric and pancreatic cancer predisposition syndromes]. Gastroenterol Hepatol 2016;39:481-93. [PMID: 26916701 DOI: 10.1016/j.gastrohep.2015.11.009] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
376 Huynh JM, Laukaitis CM. Panel testing reveals nonsense and missense CDH1 mutations in families without hereditary diffuse gastric cancer. Mol Genet Genomic Med. 2016;4:232-236. [PMID: 27064202 DOI: 10.1002/mgg3.197] [Cited by in Crossref: 17] [Cited by in F6Publishing: 21] [Article Influence: 2.4] [Reference Citation Analysis]
377 Colonna S, Gammon A. Management of the Patient with a Genetic Predisposition for Breast Cancer. Management of Breast Diseases 2016. [DOI: 10.1007/978-3-319-46356-8_31] [Reference Citation Analysis]
378 Sakellis CG, Jacene HA, Van den Abbeele AD. Diagnostic Applications of Nuclear Medicine: Gastric Cancers. Nuclear Oncology 2016. [DOI: 10.1007/978-3-319-26067-9_14-1] [Reference Citation Analysis]
379 van der Post RS, Gullo I, Oliveira C, Tang LH, Grabsch HI, O'Donovan M, Fitzgerald RC, van Krieken H, Carneiro F. Histopathological, Molecular, and Genetic Profile of Hereditary Diffuse Gastric Cancer: Current Knowledge and Challenges for the Future. Adv Exp Med Biol 2016;908:371-91. [PMID: 27573781 DOI: 10.1007/978-3-319-41388-4_18] [Cited by in Crossref: 36] [Cited by in F6Publishing: 36] [Article Influence: 5.1] [Reference Citation Analysis]
380 Llort G, Chirivella I, Morales R, Serrano R, Sanchez AB, Teulé A, Lastra E, Brunet J, Balmaña J, Graña B; SEOM Hereditary Cancer Working Group. SEOM clinical guidelines in Hereditary Breast and ovarian cancer. Clin Transl Oncol 2015;17:956-61. [PMID: 26669313 DOI: 10.1007/s12094-015-1435-3] [Cited by in Crossref: 58] [Cited by in F6Publishing: 48] [Article Influence: 7.3] [Reference Citation Analysis]
381 Pernot S, Voron T, Perkins G, Lagorce-Pages C, Berger A, Taieb J. Signet-ring cell carcinoma of the stomach: Impact on prognosis and specific therapeutic challenge. World J Gastroenterol 2015; 21(40): 11428-11438 [PMID: 26523107 DOI: 10.3748/wjg.v21.i40.11428] [Cited by in CrossRef: 153] [Cited by in F6Publishing: 168] [Article Influence: 19.1] [Reference Citation Analysis]
382 van der Post RS, Vogelaar IP, Manders P, van der Kolk LE, Cats A, van Hest LP, Sijmons R, Aalfs CM, Ausems MG, Gómez García EB, Wagner A, Hes FJ, Arts N, Mensenkamp AR, van Krieken JH, Hoogerbrugge N, Ligtenberg MJ. Accuracy of Hereditary Diffuse Gastric Cancer Testing Criteria and Outcomes in Patients With a Germline Mutation in CDH1. Gastroenterology 2015;149:897-906.e19. [PMID: 26072394 DOI: 10.1053/j.gastro.2015.06.003] [Cited by in Crossref: 57] [Cited by in F6Publishing: 62] [Article Influence: 7.1] [Reference Citation Analysis]
383 Setia N, Clark JW, Duda DG, Hong TS, Kwak EL, Mullen JT, Lauwers GY. Familial Gastric Cancers. Oncologist. 2015;20:1365-1377. [PMID: 26424758 DOI: 10.1634/theoncologist.2015-0205] [Cited by in Crossref: 34] [Cited by in F6Publishing: 35] [Article Influence: 4.3] [Reference Citation Analysis]
384 Arifi S, Elmesbahi O, Amarti Riffi A. Primary signet ring cell carcinoma of the colon and rectum. Bull Cancer 2015;102:880-8. [PMID: 26412710 DOI: 10.1016/j.bulcan.2015.07.005] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 1.8] [Reference Citation Analysis]
385 Chikman B, Davidson T, Kais H, Jeroukhimov I, Leshno A, Sandbank J, Halevy A, Lavy R. Is there an association between invasive lobular carcinoma of the breast and a family history of gastric cancer? Familial Cancer 2016;15:41-7. [DOI: 10.1007/s10689-015-9833-9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
386 Figueiredo C, Costa S, Karameris A, Machado JC. Pathogenesis of Gastric Cancer. Helicobacter 2015;20 Suppl 1:30-5. [PMID: 26372822 DOI: 10.1111/hel.12254] [Cited by in Crossref: 29] [Cited by in F6Publishing: 32] [Article Influence: 3.6] [Reference Citation Analysis]
387 Thomas RM, Jobin C. The Microbiome and Cancer: Is the 'Oncobiome' Mirage Real? Trends Cancer 2015;1:24-35. [PMID: 26568984 DOI: 10.1016/j.trecan.2015.07.005] [Cited by in Crossref: 51] [Cited by in F6Publishing: 56] [Article Influence: 6.4] [Reference Citation Analysis]
388 Benusiglio PR, Colas C, Rouleau E, Uhrhammer N, Romero P, Remenieras A, Moretta J, Wang Q, De Pauw A, Buecher B, Stoppa-Lyonnet D, Mouret-Fourme E, Noguès C, Di Maria M, Tlemsani C, Warcoin M, Grandjouan S, Malka D, Caron O, Blayau M. Hereditary diffuse gastric cancer syndrome: improved performances of the 2015 testing criteria for the identification of probands with a CDH1 germline mutation. J Med Genet 2015;52:563-5. [PMID: 26025002 DOI: 10.1136/jmedgenet-2015-103153] [Cited by in Crossref: 13] [Cited by in F6Publishing: 17] [Article Influence: 1.6] [Reference Citation Analysis]
389 Haverkamp L, van der Sluis PC, Ausems MG, van der Horst S, Siersema PD, Ruurda JP, Offerhaus GJ, van Hillegersberg R. Prophylactic Laparoscopic Total Gastrectomy with Jejunal Pouch Reconstruction in Patients Carrying a CDH1 Germline Mutation. J Gastrointest Surg 2015;19:2120-5. [PMID: 26443527 DOI: 10.1007/s11605-015-2963-4] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 1.8] [Reference Citation Analysis]
390 [DOI: 10.1101/2020.06.01.20118471] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
391 [DOI: 10.1101/764779] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Reference Citation Analysis]